Home
  >  
Section 35

EurekaMag Full Text Articles Chapter 34,764



References:

Fagot, J.; Thieren, Y. 1999: Donacia dentata Hoppe two steps away from Belgium Update on Chrysomelidae in Belgium and two bordering areas. Bulletin de la Societe Royale Belge d'Entomologie 135(1-6): 48-50
Bevan, M.; Pious, D.A. 1999: Donald A. Pious 1930-1998. Experimental and Clinical Immunogenetics 16(2): 124
Anonymous 2001: Donald Alexander Titchen. Australian Veterinary Journal 79(12): 846
Johnson, R.A.; Ellingson, R.J.; Wilson, C.L.; Edgerton, V.R.ggie 2004: Donald B Lindsley, 95, Honorary Consulting Editor, Clinical Neurophysiology. Clinical Neurophysiology 115(1): 1-3
Munk Jorgensen, Povl 2004: Donald C Goff - Biography. Acta Psychiatrica Scandinavica 110(4): 320
Ramachandran, J.; Hruby, V.J. 2000: Donald H Yamashiro. Journal of Peptide Research 56(6): 335-336
Eastick, B. 2004: Donald Newell Mackie - 6 November 1922-3 March 2004. Australian Veterinary Journal 82(6): 379
Simmons, J.A. 2004: Donald R Griffin. Bat Research News 45(1): 28-30
Sutherland, A.K.; Arundel, J.H. 1999: Donald Thomas Oxer, DVSc FACVSc FAVA. Australian Veterinary Journal 77(7): 470
Solomon, M.Z. 2003: Donation after cardiac death: non-heart-beating organ donation deserves a green light and hospital oversight. Anesthesiology 98(3): 601-602
Kim, K.S.; Kim, J.H.; Jeon, K.O.; Park, Y.N.; Kim, M.J.; Lee, W.J.; Kim, S.I.; Kim, B.R.; Han, K.H.; Chon, C.Y. 2002: Donation failure in living donor liver transplantation. Hepatology 36(4 Part 2): 665A
Field, S.P. 2004: Donation in populations with high endemic virus infection. Vox Sanguinis 87(Suppl 2): 19-21
Hombauer, H.; Bittner, R.E.; Fischer, P.; Huber, K.; Tragl, K.H. 2001: Donauspital-study on the prediction of memory loss and dementia in Vienna; is Alzheimers disease related to mutations in the mitochondrial DNA?. European Journal of Human Genetics 9(Suppl 1): P1336
Wilcock, G.K.; Whitehead, A.; Evans, J.G.; Birks, J.; Perdomo, C.; Pratt, R.D. 2001: Donepezil A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimers disease. Neurology 56(8 Suppl 3): A339
Dooley, M.; Lamb, H.M. 2000: Donepezil: a review of its use in Alzheimer's disease. Drugs and Aging 16(3): 199-226
Goldsmith, D.R.; Scott, L.J. 2003: Donepezil: in vascular dementia. Drugs and Aging 20(15): 1127-1136
Vicenzini, E.; Altieri, M.; Pestalozza, I.; Rocco, A.; Calabresi, M.; Di Piero, V.; Lenzi, G.L. 2002: Donepezil and motor performances in chronic stroke A preliminary clinical experience. Journal of the Neurological Sciences (203-204): 338
Carrier, L. 1999: Donepezil and paroxetine: possible drug interaction. Journal of the American Geriatrics Society 47(8): 1037
Mcrae, T.; Griesing, T.; Whalen, E. 2000: Donepezil and sertraline for the management of behavioral symptoms in patients with Alzheimers disease. Neurology 54(7 Supp 3): A416-A417
Tuma, I.; Lenderova, Z.; Zemanova, M.; Kadlecova, E.; Perez, M. 2003: Donepezil as an adjunctive treatment of cognitive dysfunction in schizophrenia. European Neuropsychopharmacology 13(Suppl 4): S348-S349
Waldemar, G.; Winblad, B.; Engedal, K.; Soininen, H.S.; Verhey, F.R.J.; Wimo, A.; Wetterholm, A.L.; Zhang, R.; Haglund, A.A.; Subbiah, P. 2000: Donepezil benefits patients with either mild or moderate Alzheimers disease over one year. Neurology 54(7 Supp 3): A470
Froelich, L.; Gertz, H.J.; Heun, R.; Heuser, I.; Jendroska, K.; Kornhuber, J.; Kurz, A.; Mueller Thomsen, T.; Ries, F.; Waechtler, C.; Metz, M.; Goebel, C. 2000: Donepezil for Alzheimers Disease The donald study A multicenter 24 weeks clinical trial in Germany. European Neuropsychopharmacology 10(Suppl 3): S360-S361
Riepe, M.W.; Jendroska, K.; Horn, R.; Kohler, J.; Moebius, J.; Diener, H.C. 2003: Donepezil for the treatment of demented patients with and without cerebrovascular cofactors Effects on individual symptoms. European Journal of Neurology 10(Suppl 1): 159
Krupp, L.B.; Elkins, L.E.; Scott, S.R.; Smiroldo, J.; Coyle, P.K. 1999: Donepezil for the treatment of memory impairments in multiple sclerosis. Neurology 52(6 Suppl 2): A137
Fergusson, E.; Howard, R. 2000: Donepezil for the treatment of psychosis in dementia with Lewy bodies. International Journal of Geriatric Psychiatry 15(3): 280-281
Feldman, H.; Gauthier, S.; Hecker, J.; Vellas, B.; Xu, Y.; Ieni, J.; Schwam, E. 2003: Donepezil has significant functional and behavioral benefits in patients with severe Alzheimers disease. European Neuropsychopharmacology 13(Suppl 4): S402
Engedal, K.; Soininen, H.; Verhey, F.; Waldemar, G.; Winblad, B.; Wimo, A.; Wetterholm, A.L.; Zhang, R.; Haglund, A.; Subbiah, P. 2000: Donepezil improved or stabilized cognition over one year in patients with mild and moderate Alzheimers disease. European Neuropsychopharmacology 10(Suppl 3): S368
Pratt, R.D.; Perdomo, C.A.; Donepezil 307 Study Group 2002: Donepezil improves cognitive function in patients with vascular dementia Results from study 307, a 24-week, randomized, double-blind, placebo-controlled trial. Neurology 58(7 Suppl 3): A161-A162
Ieni, J.R.; Pratt, R.D.; Perdomo, C.A. 1999: Donepezil in Alzheimers disease patients Integrated safety results from the clinical trial program. Journal of the American Geriatrics Society 47(9): S63
Shua Haim, J.R.; Shua Haim, V.; Ross, J.S. 1999: Donepezil in the treatment of Age Acquired Cognitive Deficit A preliminary impression. Journal of the American Geriatrics Society 47(9): S88
Cummings, J.L.; Katz, I.R.; Tariot, P.; Perdomo, C.A.; Whalen, E.; Schwam, E.M. 1999: Donepezil in the treatment of Alzheimers disease in a nursing home population. Neurology 52(6 Suppl 2): A481
Kemmerich, M.; Quartz, P.; Berger, F.M.; Kuethmann, A. 2000: Donepezil in therapy-refractory depression. European Neuropsychopharmacology 10(Suppl 3): S264
Winblad, B.; Engedal, K.; Soininen, H.; Verhey, F.; Waldemar, G.; Wimo, A.; Wetterholm, A.L.; Haglund, A.; Zhang, R.; Burger, L.; Schindler, R. 2003: Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimers disease Results from a 1-year placebo-controlled study and 2-year follow-up Study. European Journal of Neurology 10(Suppl 1): 158
Winblad, B.; Engedal, K.; Soininen, H.; Verhey, F.R.J.; Waldemar, G.; Wimo, A.; Wetterholm, A.L.; Haglund, A.; Zhang, R.; Burger, L.; Schindler, R. 2003: Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimers disease Results from a patient cohort who completed a one-year placebo-controlled Study and participated in a two-year follow-up Study. European Neuropsychopharmacology 13(Suppl 4): S402-S403
Moeller, J.R.; Rusinek, H.; Casanova, M.F.; Hoffman, J.M.; Votaw, J.R.; Tune, L.M.; Perdomo, C.; Pratt, R.D.; Ieni, J.R.; Jewart, R.D. 2003: Donepezil maintains activity in a specific neural network in patients with Alzheimers disease. European Journal of Neurology 10(Suppl 1): 153
Mohs, R.; Doody, R.; Morris, J.; Ieni, J.; Perdomo, C.; Pratt, R.; Rogers, S. 2000: Donepezil preserves activities of daily living in Alzheimers disease patients Results from a one-year placebo-controlled functional survival study. Neurology 54(7 Supp 3): A415
Mohs, R.; Doody, R.; Morris, J.; Rogers, S.; Ieni, J.; Perdomo, C.; Pratt, R. 2000: Donepezil preserves functional status in Alzheimers disease patients Results from a 1-year functional survival study. European Journal of Neurology 7(Suppl 3): 25-26
Feldman, H.; Gauthier, S.; Hecker, J.; Vellas, B.; Subbiah, P.; Whalen, E. 2000: Donepezil provides benefits in global function in moderate to severe Alzheimers disease. European Journal of Neurology 7(Suppl 3): 133
Berger, F.; Sramko, C.A.; Froelich, L.; Calabrese, P. 2000: Donepezil provides relevant therapeutic benefits in different domains to real world patients with Alzheimers disease. European Neuropsychopharmacology 10(Suppl 3): S369
Wimo, A.; Winblad, B.; Mastey, V.; Haglund, A.; Jacobson, L.; Miceli, R.; Hertzman, P.; Chin, W.; Subbiah, P. 2000: Donepezil reduces total healthcare and societal costs in patients with mild to moderate Alzheimers disease Results of a one-year, double-blind, randomized trial. European Journal of Neurology 7(Suppl 3): 25
Feldman, H.; Gauthier, S.; Hecker, J.; Vellas, B.; Xu, Y.; Ieni, J.R.; Schwam, E. 2003: Donepezil shows benefits in patients with moderate to severe Alzheimers disease , independent of baseline dementia severity. European Journal of Neurology 10(Suppl 1): 158-159
Wimo, A.; Winblad, B.; Shah, S.; Haglund, A.; Zhang, R.; Miceli, R.; Chin, W. 2003: Donepezil treatment in Alzheimers disease patients Caregiver health benefits and associated reductions in healthcare costs. European Journal of Neurology 10(Suppl 1): 24
Aarsland, D.; Larsen, J.P.; Janvin, C.; Laake, K. 2001: Donepezil treatment in Parkinsons disease with dementia A double-blind, placebo-controlled crossover study. Neurology 56(8 Suppl 3): A128
Meyer, J.S.; Chowdhury, M.H.; Xu, G.; Li, Y.-S.; Quach, M. 2002: Donepezil treatment of vascular dementia. Annals of the new York Academy of Sciences 977: 482-486
Tariot, P.; Cummings, J.L.; Katz, I.R.; Perdomo, C.A.; Whalen, E.; Sovel, M.A.; Schwam, E.M. 1999: Donepezil was well-tolerated and enhanced cognition in nursing home patients with Alzheimers disease. Journal of the American Geriatrics Society 47(9): S3
Kato, M.; Funaki, Y.; Iwata, R.; Sakurai, E.; Yanai, K. 2002: Donepezil, a radiotracer for acetylcholinesterase Radiochemical synthesis and binding characteristics in the rat brain. Japanese Journal of Pharmacology 88(Suppl 1): 203P
Hayslett, R.L.; Tizabi, Y. 2003: Donepezil, nicotine and the combination reduce DOI-induced head twitch response in mice implications for Tourette syndrome. FASEB Journal 17(4-5): Abstract 390
Triau, E.; Hasselbalch, S.; Ihl, R.; Jakab, G.; Kloszewska, I.; Mccarthy, J.; Tsolaki, M.; Wouters, C.J.; Johannsen, P. 2003: Donepezil-treated Alzheimers disease patients with apparent initial cognitive decline demonstrate significant benefits when therapy is continued Results from a randomized, placebo-controlled Trial. European Journal of Neurology 10(Suppl 1): 23-24
Wilkinson, D.G.; Pratt, R.D.; Perdomo, C.A. 2003: Donepezil-treated VaD patients demonstrate global benefits A comparison of the CIBIC-plus vs CDR-SB. European Journal of Neurology 10(Suppl 1): 136-137
Bayer, A.; Wilkinson, D.G.; Pratt, R.D.; Perdomo, C.A.; Donepezil 307 And 308 Vad Study Groups 2003: Donepezil-treated patients demonstrate cognitive and global benefits A comparison of Alzheimers disease vs vascular dementia. European Journal of Neurology 10(Suppl 1): 25
Doody, R.S.; Pratt, R.D.; Perdomo, C.A. 2003: Donepezil-treated patients demonstrate global benefits on the clinicians interview-based impression of change-plus version A comparison of Alzheimers disease versus vascular dementia. Neurology 60(5 Suppl 1): A412
Pratt, R.D.; Perdomo, C.A. 2002: Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits. Annals of the new York Academy of Sciences 977: 513-522
Verhey, F.; Winblad, B.; Engedal, K.; Soininen, H.; Waldemar, G.; Wimo, A.; Wetterholm, A.L.; Zhang, R.; Haglund, A.; Subbiah, P. 2000: Donepezils beneficial effects on activities of daily living over one year in patients with mild to moderate Alzheimers disease. European Journal of Neurology 7(Suppl 3): 24
John, Gareth W.; Perez, Michel; Pauwels, Petrus J.; Le Grand, Bruno; Verscheure, Yvan; Colpaert, Francis C. 2000: Donitriptan, a unique high-efficacy 5-HT1B/1D agonist Key features and acute antimigraine potential. CNS Drug Reviews 6(4): 278-289
Greco, D.; Cuoco, C.; Di Rocco, M.; Romano, C. 2002: Donohue syndrome in a boy with 13q123-q212 deletion. European Journal of Human Genetics 10(Suppl 1): 125
Edinger, M.; Hoffmann, P.; Ermann, J.; Drago, K.; Beilhack, A.; Fathman, C.G.; Strober, S.S.; Negrin, R.S. 2002: Donor CD4+CD25+ Regulatory T Cells Suppress Acute GVHD Lethality without Loss of GVL Activity. Blood 100(11): Abstract No. 535
Hanash, A.M.; Levy, R.B. 2002: Donor CD4+CD25+ Regulatory T-Cells Can Support Engraftment in the Absence of GVHD during Non-Myeloablative Allogeneic Murine Bone Marrow Transplantation. Blood 100(11): Abstract No. 801
Hanash, A.M.; Levy, R.B. 2003: Donor CD4+CD25+ T-cells facilitate hematopoietic engraftment independent of host resistance and allo-antigen recognition. Blood 102(11): 38a
Isola, L.M.; Chao, N.J.; Weinberg, R.S.; Fruchtman, S.M.; Atweh, G.; Mccune, S.; Telen, M.J.; Decastro, L.M.; Long, G.D.; Vredenburgh, J.J.; Gasparetto, C.; Liesveld, 2002: Donor Chimerism after T-Cell Depleted -Non-Myeloablative Allogeneic SCT in Hemoglobinopathies. Blood 100(11): Abstract No. 5172
Olszewski, W.L.; Durlik, M.; Lukomska, B.; Religa, P.; Janczewska, S.; Cybulska, E.; Soin, J.; Gaciong, Z. 1999: Donor DNA can be detected in recipient tissues and serum during rejection of allograft. Cell Transplantation 8(2): 180
Interewicz, B.; Olszewski, W.L.; Maksymowicz, M.; Stanislawska, J.; Szyper, E.; Cybulska, E. 2002: Donor DNA from rejecting organ and tissue grafts can be detected in recipient tissues. Transplantation Proceedings 34(2): 699-700
Shlomchik, W.D.; Cormier, J.; Matte, C.; Anderson, B.; Shlomchik, M.J. 2002: Donor Derived Antigen Presenting Cells Are Not Required for CD8 T Cell Induced GVHD. Blood 100(11): Abstract No. 3239
Beige, J.; Engeli, S.; Ringel, J.; Offermann, G.; Distler, A.; Sharma, A.M. 1999: Donor G-protein beta3 subunit C825T genotype is associated with kidney allograft survival. Kidney and Blood Pressure Research 22(4-6): 394-395
Kerman, R.H.; Gibson, H.; Van Buren, C.T.; Reena, S.; Garcia, C.; Mckissick, E.; Olivarez, C.; Knight, R.; Katz, S.M.; Kahan, B.D. 2002: Donor HLA, transplant, and graft loss result in similar recipient sensitization not affecting retransplant survival. Human Immunology 63(Suppl 1): S77
Battiwalla, M.; Cavet, J.; Hensel, N.; Cullup, H.; Dickinson, A.; Nakamura, R.; Follman, D.; Childs, R.; Middleton, P.; Barrett, A.J.hn 2002: Donor IL-1 Ra Gene Polymorphisms Affect In Vitro and In Vivo Responses to CMV Antigen. Blood 100(11): Abstract No. 2465
Depil, S.; Cornillon, J.; Deconninck, E.; Milpied, N.; Sutton, L.; Witz, F.; Jouet, J.P.; Yakoub Agha, I. 2002: Donor Lymphocyte Infusion To Treat Relapse after Allogeneic Bone Marrow Transplantation for Myelodysplastic Syndrome On Behalf of the Societe Francaise de Greffe de Moelle et Therapie Cellulaire. Blood 100(11): Abstract No. 2488
Lee, K.E.; Jung, C.W.; Kim, K.; Lee, M.H.; Park, K.; Kim, D.Y.; Yoon, S.S.; Park, S.; Kim, B.K. 2002: Donor Lymphocyte Infusion in Relapsed Hematologic Malignancies after Allogeneic Stem Cell Transplantation. Blood 100(11): Abstract No. 5384
Bethge, W.A.; Maris, M.B.; Flowers, M.E.D.; Maloney, D.G.; Niederwieser, D.; Chauncey, T.; Blume, K.G.; Forman, S.J.; Storb, R.; Sandmaier, B.M. 2002: Donor Lymphocyte Infusions after Nonmyeloablative Marrow Transplantation. Blood 100(11): Abstract No. 2487
Raptis, A.; Ballester, O.; Grutsch, J.F.; Williams, S.; Tan, B.; Wilcox, P.; Payne, M.; Braun, B. 2002: Donor Lymphocyte Infusions and IL-2 as Adaptive Immunotherapy for Patients with Advanced Malignancies Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplant. Blood 100(11): Abstract No. 5381
Marktel, S.; Crawley, C.; Szydlo, R.; Rahemtulla, A.; Kanfer, E.; Olavarria, E.; Marin, D.; Apperley, J.F.; Goldman, J.M. 2002: Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Factors Influencing the Effective Cell Dose. Blood 100(11): Abstract No. 3103
Liu, Q.; Sun, J.; Liu, X.; Zhou, S. 2002: Donor Lymphocyte Infusions in Patients with Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation. Blood 100(11): Abstract No. 5366
Zhang, Z.; Barrett, T.A.; Kaptanoglu, L.; Ivancic, D.; Luster, A.D.; Fryer, J.P. 2002: Donor T cell activation initiated small bowel allograft rejection is dependent upon IFN-gamma inducible protein-10. Gastroenterology 123(1 Suppl): 18
Battiwalla, M.; Kurlander, R.; Solomon, S.R.; Wehrlen, L.; Greene, A.; Barrett, A.J.hn 2003: Donor T lymphocyte engraftment is facilitated by higher CD34 cell doses in T cell depleted myeloablative allogeneic peripheral blood stem cell transplantation. Blood 102(11): 709a
André-Schmutz, I.; Le Deist, F.; Hacein-Bey, S.; Hamel, Y.; Vitetta, E.; Schindler, J.; Fischer, A.; Cavazzana-Calvo, M. 2002: Donor T lymphocyte infusion following ex vivo depletion of donor anti-host reactivity by a specific anti-interleukin-2 receptor P55 chain immunotoxin. Transplantation Proceedings 34(7): 2927-2928
Mena, O.J.; Carvallo, C.; Drachenberg, D.E.; Srinivasan, R.; Igarashi, T.; Linehan, W.M.; Childs, R. 2002: Donor T-cells mediate regression of metastatic renal cell carcinoma following non-myeloablative allogeneic stem cell transplantation. Journal of Urology 167(4 Suppl): 123
Fowler, D.H.; Hou, J.; Fellowes, V.; Vance, B.; Bishop, M.R.; Gress, R.E.; Levine, B.; June, C.; Leitman, S.; Read, E.J.; Carter, C. 2002: Donor Th2 Cells for GVHD Modulation Clinical Scale and Grade Generation Using CD3, CD28 Co-Stimulation. Blood 100(11): Abstract No. 648
Nguyen, T.D.; Porter, J.M.; Haddock, A.; Roberts, S.; Maness, S.R. 1999: Donor acceptance of biometric identification A finger scanning study. Transfusion 39(10 Suppl): 127S
Alonso, M.; Fernández, M.; Mataix, R.; Rincón, M.D.; Corrales, J.A.; Burgos, R.; Miranda, B. 1999: Donor action in Spain: a program to increase organ donation. Transplantation Proceedings 31(1-2): 1084-1085
Middleton, R.J.; Agrawal, A.; Tavakoili, A.; Valentine, A.; Augustine, T.; Parrott, N.R.; Short, C.D.; Riad, H.N. 2003: Donor age and MDRD GFR estimates are the most useful predictors of recipient outcomes in live-donor transplantation. Journal of the American Society of Nephrology 14(Abstracts Issue): 668A
Caballero, F.; López-Navidad, A.; Leal, J.; García-Sousa, S.; Domingo, P. 1999: Donor age and cause of brain death influence the number of organs retrieved and grafted. Transplantation Proceedings 31(6): 2589-2590
Rifai, K.; Sebagh, M.; Karam, V.; Adam, R.; Castaing, D.; Bismuth, H.; Samuel, D.; Reynes, M.; Feray, C. 2004: Donor age and graft histology ten years after liver transplantation. Journal of Hepatology 40(Suppl 1): 53
Samonakis, D.N.; Triantos, C.K.; Thalheimer, U.; Quaglia, A.; Leandro, G.; Papatheodoridis, G.V.; Teixeira, R.; Raimondo, M.L.; Rolando, N.; Dhillon, A.P.; Patch, D.W.; Davidson, B.R.; Rolles, K. 2004: Donor age does not influence progression of HCV recurrence after liver transplantation. Journal of Hepatology 40(Suppl 1): 6-7
Janssen, H.; Malagò, M.; Erhard, J.; Lange, R.; Testa, G.; Vester, U.; Eigler, F.W.; Broelsch, C.E. 2001: Donor age in liver transplantation: is there a limit?. Transplantation Proceedings 33(1-2): 1504
Shaw, B.E.; Marsh, S.G.E.; Mayor, N.P.; Prentice, H.G.; Pay, A.L.; Little, A.M.; Potter, M.N.; Madrigal, J.A. 2002: Donor age is not a significant factor affecting overall survival in HLA matched unrelated donor stem cell transplants. Tissue Antigens 59(2 Suppl): 90-91
Potena, L.; Grigioni, F.; Ortolani, P.; Magnani, G.; Falchetti, E.; Barbieri, A.; Marrozzini, C.; Marzocchi, A.; Magelli, C.; Branzi, A. 2001: Donor and de novo plaque burden do not influence coronary artery remodeling in heart transplant recipients. Circulation 104(17): 2; 236
Murphy, M.F.; Howell, C.; Seghatchian, J. 1999: Donor and operational acceptability of Cobe Trima and evaluation of responses to platelet transfusions. Transfusion 39(10 Suppl): 28S
Operskalski, E.A.; Tobler, L.H.; Mosley, J.W.; Busch, M.P. 2002: Donor and recipient HCV indices by genotype. Vox Sanguinis 83(Suppl 2): 136
Gagne, K.; Denis, L.; Saintol, N.; Gueglio, B.; Milpied, N.; Cesbron, A.; Follea, G.; Harrousseau, J.L.; Bignon, J.D. 2003: Donor and recipient KIR gene mismatching correlates with GVHD occurrence in allogeneic bone marrow transplantation. Genes and Immunity 4(Suppl 1): S10
Goldfarb Rumyantzev, A.S.; Pappas, L.; Scandling, J.D.; Smout, R.J.; Horn, S. 2002: Donor and recipient anthropometric characteristics and long term cadaveric kidney allograft outcome. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 770A
Brown, S.A.; Konopa, J.L.; Zhou, D.; Thompson, J.S. 2002: Donor and recipient cells produce TNF-alpha following irradiation conditioning and spleen cell transplantation. FASEB Journal 16(5): A1036
Richard, R.; Verdier, J.C.; Pavie, A.; Rieu, M. 2002: Donor and recipient characteristics that influence functional capacity of heart transplant recipients. Transplantation Proceedings 34(4): 1262-1264
Kim, W.R.; Wiesner, R.H.; Therneau, T.M.; Poterucha, J.J.; Rosen, C.B.; Klintmalm, G.B.; Dickson, E.R. 2000: Donor and recipient predictors of patient and graft survival following liver transplantation. Hepatology 32(4 Pt 2): 253A
Bang, K.W.A.; Hannach, B.; Fabron, A.J.; Kovalovsky, E.; Farkas, S.; Tinmouth, A.; Mody, M.; Shakoor, S.; Freedman, J. 2003: Donor anti-WBC specificities in TRALI A Canadian experience. Blood 102(11): 558a
Norin, A.J.; Brewer, R.J.; Lui, Q.; Del Rio, M.J.; Burack, J.; Kamholz, S.L. 1999: Donor antigen-independent effector mechanisms of graft rejection: a novel cell surface target of IL-2-activated natural killer cells. Transplantation Proceedings 31(1-2): 787-788
Parihar Malhotra, M.; Shah, S.; Devraj, H.; Nambiar, R. 2002: Donor awareness Blood bank role. Vox Sanguinis 83(Suppl 2): 169
Wu, Y.; Kleinman, S.H.; Schreiber, G.B.; Busch, M.P.; Ameti, D.I.; Williams, A.E. 1999: Donor behaviors after notification of abnormal laboratory test results. Transfusion 39(10 Suppl): 113S
Kraus, M.; Shemesh, E. 2004: Donor blood sampling system. Official Gazette of the United States Patent and Trademark Office Patents 1279(3)
George, J.F.; Goldstein, D.R.; Chang, T.; Kirklin, J.K.; Thomas, J.M. 2000: Donor bone marrow cells and donor splenocytes augment allograft survival by distinct molecular mechanisms. Journal of Heart and Lung Transplantation 19(1): 50-51
Mathew, J.M.; Fuller, L.; Carreno, M.; Burke, G.W.; Ciancio, G.; Ricordi, C.; Tzakis, A.G.; Esquenazi, V.; Miller, J. 2001: Donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation as regulators of autologous immune responses. Transplantation Proceedings 33(1-2): 108-109
Chen, J.; He, Q.; Wu, J.; Wang, R. 2003: Donor bone marrow infusion in Chinese kidney transplant recipients A single center experience. Journal of the American Society of Nephrology 14(Abstracts Issue): 434A
Ciancio, G. 2003: Donor bone marrow infusion in cadaveric renal transplantation. Transplantation Proceedings 35(2): 871-872
Rao, A.S.; Dvorchik, I.; Dodson, F.; Abu-Elmagd, K.; Schaefer, A.T.; Ostrowski, L.; Valenti, M.; Zeevi, A.; Kuddus, R.; Starzl, T.E.; Fung, J.J. 2001: Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection. Transplantation Proceedings 33(1-2): 1352
Ciancio, G.; Garcia-Morales, R.; Mathew, J.; Carreno, M.; Burke, G.W.; Ricordi, C.; Kenyon, N.; Esquenazi, V.; Cirocco, R.; Tzakis, A.; Miller, J. 2001: Donor bone marrow infusions are tolerogenic in human renal transplantation. Transplantation Proceedings 33(1-2): 1295-1296
Ciancio, G.; Garcia-Morales, R.; Burke, G.W.; Roth, D.; Esquenazi, V.; Tzakis, A.; Miller, J. 1999: Donor bone marrow, chimerism, histocompatibility and renal allograft rejection. Transplantation Proceedings 31(1-2): 679
Liu, Y.; Hamrah, P.; Zhiang, Q.; Taylor, A.W.; Dana, M.R. 2001: Donor bone marrow-derived antigen-presenting cells traffic to draining lymph nodes after corneal transplantation. IOVS Investigative Ophthalmology and Visual Science 42(4): S470
Wilhelm, M.J.; Pratschke, J.; Kusaka, M.; Hancock, W.W.; Tilney, N.L. 1999: Donor brain death affects tempo and intensity of acute rejection of rat chronic allografts. Transplantation Proceedings 31(1-2): 1008-1009
Wilhelm, M.J.; Pratschke, J.; Beato, F.; Taal, M.; Schmid, C.; Scheld, H.H.; Hancock, W.W.; Tilney, N.L. 2002: Donor brain death intensifies the recipient inflammatory response in chronic rat cardiac allograft rejection. Journal of Heart and Lung Transplantation 21(1): 137-138
Kown, M.H.; Murata, S.; Jahncke, C.L.; Mari, C.; Berry, G.J.; Lijkwan, M.A.; Blankenberg, F.G.; Strauss, H.W.; Robbins, R.C. 2002: Donor cardiac allografts from p53 knockout mice exhibit apoptosis-independent prolongation of survival. Transplantation Proceedings 34(8): 3274-3276
Pehlivan, M.; Gunson, B.; Chen, J.W.; Khantaria, C.; Mayer, D.; Buckels, J.; Mcmaster, P.; Mirza, D.; Candinas, D. 2001: Donor cardiovascular instability is not a major determinant of outcome in liver transplantation. Hepatology 34(4 Pt 2): 205A
Ganesh, J.S.; Rogers, C.A.; Banner, N.R.; Bonser, R.S. 2004: Donor cause of death does not affect medium-term survival after heart transplantation A UK National Study. Journal of Heart and Lung Transplantation 23(2S): S49
Ganesh, J.S.; Rogers, C.A.; Banner, N.R.; Bonser, R.S. 2004: Donor cause of death does not influence mid-term survival in lung transplant recipients. Journal of Heart and Lung Transplantation 23(2S): S131-S132
Stoolman, L.M.; Skitzki, J.; Okuyama, R.; March, C.A.; Knibbs, R.N.; Craig, R.A. 2004: Donor cell cycling, trafficking, accumulation and clinical activity during adoptive immunotherapy. FASEB Journal 18(4-5): Abstract 85
Hambach, L.; Eder, M.; Dammann, E.; Battmer, K.; Stucki, A.; Heil, G.; Ganser, A.; Hertenstein, B. 2000: Donor cell derived acute myelocytic leukemia developing 14 month after matched unrelated bone marrow transplantation for chronic myelocytic leukemia. Onkologie 23(Sonderheft 7): 75
Wang, C.; Sun, J.; Horvat, M.; Koutalistras, N.; Sheil, A.G. 2001: Donor cell migration and graft-infiltrating cell apoptosis in heart acceptance in a multiorgan transplant model. Transplantation Proceedings 33(1-2): 135
Beyhan, Z.; Mitalipova, M.; Chang, T.C.; First, N. 2002: Donor cell passage number, starvation period and fusion-activation interval affect preimplantation development of bovine nuclear transfer embryos. Theriogenology 57(1): 396
Meyer, D.; Löffeler, S.; Otto, C.; Gassel, H.J.; Timmermann, W.; Ulrichs, K.; Thiede, A. 1999: Donor cell population in the liver allograft reflects the recipient immune status. Transplantation Proceedings 31(1-2): 437
Tsunoda, Y.kio 2002: Donor cell type and cloning efficiency in mammals. Cloning and Stem Cells 4(3): 280
Hayamizu, K.; Zeng, D.; Strober, S. 1999: Donor cells that facilitate tolerance to rat heart allografts after posttransplant total lymphoid irradiation and rabbit anti-thymocyte globulin. Transplantation Proceedings 31(3b Suppl): 25s-26s
Westgren, L.; Anneren, G.; Axelsson, O.; Evald, U.; Leblanc, K.; Ringden, O. 2003: Donor chimerism across full allogenic barriers achieved by in utero transplantation of fetal mesenchymal stem cells in a case of osteogenesis imperfecta. American Journal of Obstetrics and Gynecology 189(6 Suppl): S215
Esparza, C.; Mendez, R.; Serrano, A.; Romero, A.; Garrido, F.; Ruiz Cabello, F. 2002: Donor chimerism and immune modulating effect of alloreactive cells after reduced toxic conditioning regiment. European Journal of Immunogenetics 29(2): 164
Dominko, T.; Simerly, C.; Ramalho Santos, J.; Moreno, R.; Chan, A.W.S.; Schatten, G.P. 2000: Donor chromatin transformation after nuclear transfer into metaphase II-arrested oocytes depends on the species of recipient cytoplasm. Theriogenology 53(1): 216
Ogawa, G.S.H.; Truitt, P.W.; Otten, L.J.; Soliz, P.; Erry, G.; Nemeth, S.C. 2001: Donor cornea characterization utilizing distorted grating-based wavefront analysis. IOVS Investigative Ophthalmology and Visual Science 42(4): S898
Bundy, G.M.; Baillie, G.M.; Kirtz, J.; Shafizadeh, S.F.; Rogers, J.; Lin, A.; Rajagopalan, P.R.; Chavin, K.D.; Baliga, P.K. 2001: Donor coronary angiography leads to increased post-transplant dialysis. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 926A
Gandhi, N.; Goldman, D.; Kahan, D.; Supran, S.; Saloman, R.; Delmonico, F.; O'Connor, K.; Rohrer, R.; Freeman, R. 2001: Donor cytokine gene polymorphisms are associated with increased graft loss and dysfunction after transplant. Transplantation Proceedings 33(1-2): 827-828
Hoffman, S.C.; Stanley, E.M.; Kirk, A.D.; Blair, P.J.; Mannon, R.B. 2001: Donor cytokine gene polymorphisms may predict kidney transplant outcome. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 894A
Sonmezoglu, M.; Argon, D.; Bayik, M. 2002: Donor deferral rates and reasons of deference at a University Hospital Blood Bank. Vox Sanguinis 83(Suppl 2): 171
Chiavetta, J.; Sher, G.D.; Sammon, A.K.; Ennis, M. 1999: Donor deferrals and TD risks pre and post regulatory compliance. Transfusion 39(10 Suppl): 33S
Kessler, D.; Romney, R.A.; Georges Yates, E.; Bianco, C. 1999: Donor deferrals by medical history. Transfusion 39(10 Suppl): 33S-34S
Waller, E.K.; Redei, I.; Boyer, M.; Rosenthal, H.; Langston, A. 2000: Donor dendritic cell content and donor stem cell content affect survival after allogeneic bone marrow transplantation. Bone Marrow Transplantation 25(Suppl 2): S128
Andersen, C.B.; Thomsen, O.F.; Ladefoged, J. 1999: Donor derived epstein-barr virus associated post-transplantation lymphoproliferative disorder in a second renal allograft. Virchows Archiv 435(3): 322
Manack, L.; Triulzi, D.J.; Lopez Plaza, I. 1999: Donor derived red cell antibodies in pediatric liver transplant recipients treated with FK-506. Transfusion 39(10 Suppl): 111S
Kfoury, A.G.; Myer, K.A.; Stanzione, J.R.; Tribble, C.G.; Bergin, J.D. 2003: Donor designation on the drivers license Friend or foe?. Journal of Heart and Lung Transplantation 22(1S): S88
Lenaers, J.I.V.; Christiaans, M.H.L.; Voorter, C.E.M.; Van Den Berg Loonen, E.M. 2004: Donor directed antibodies before and after transplantation as detected by donor specific flow cytometric crossmatches. Genes and Immunity 5(Suppl 1): S17
Schnuelle, P.; Yard, B.; Braun, C.; Dominguez, E.; Sturm, J.; Post, S.; Van Der Woude, F.J.hannes 2002: Donor dopamine reduces delayed graft function after kidney transplantation. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 39
Walls, D.; Porter, R.; Sandler, B.; Mukherjee, T.; Grunfeld, L.; Copperman, A.B. 2003: Donor egg pregnancy rates do not vary with stimulation protocol. Fertility and Sterility 80(Suppl 3): S245
Schnuelle, P.; Berger, S.; de Boer, J.; Persijn, G.; van der Woude, F.J. 2001: Donor employment of vasopressors and its impact on allograft survival after transplantation. Transplantation Proceedings 33(1-2): 1282-1283
Iannone, R.; Luznik, L.; Engstrom, L.W.; Fuchs, E.J. 1999: Donor erythroid chimerism in mice after non-myeloablative allogeneic stem cell transplantation. Blood 94(10 Suppl 1 Pt 2): 320b-321b
Shetty, K.; Olthoff, K.; Read, C.; Stewart, C.; Reddy, R.; Shaked, A. 2002: Donor evaluation for living donor liver transplantation Cost analysis and medical benefits. Hepatology 36(4 Part 2): 197A
Haberal, M.; Emiroglu, R.; Boyactoğlu, S.; Demirhan, B. 2002: Donor evaluation for living-donor liver transplantation. Transplantation Proceedings 34(6): 2145-2147
Frericks, B.; Calderone, F.; Schenk, A.; Peitgen, H.; Nashan, B.; Galanski, M. 2002: Donor evaluation in living related liver transplantation A new non-invasive method. Journal of Hepatology 36(Suppl 1): 37
Zafar, M.N.; Jawad, F.; Aziz, T.; Raza, Y.; Naqvi, A.; Rizvi, A. 2002: Donor follow-up in living-related renal transplantation. Transplantation Proceedings 34(6): 2443-2444
Hoffmann, S.; Jacobson, L.M.; Muehrer, R.; Park, J.; Lorentzen, D.; Chang, O.; Kleiner, D.; Kirk, A.; Mannon, R.; Becker, B.N. 2003: Donor genomics affect graft events Single nucleotide polymorphisms from the donor organ perspective. Journal of the American Society of Nephrology 14(Abstracts Issue): 64A
Jeong, D.C.; Jang, P.S.; Chung, N.G.; Kim, S.Y.; Park, S.J.; Choi, B.O.; Kim, H.; Kim, H.K.; Han, C.W. 2003: Donor graft engineering with irradiated recipient cells and IL-2 induced CD4+CD25+ cells preventing lethal GVHD. Blood 102(11): 407b
Capocasale, E.; Busi, N.; Mazzoni, M.P.; Alessandri, L.; Sianesi, M. 2002: Donor graft lithiasis in kidney transplantation. Transplantation Proceedings 34(4): 1191-1192
Diaz, G.C.; Renz, J.F.; Mudge, C.; Ascher, N.L.; Roberts, J.P.; Emond, J.C.; Rosenthal, P. 1999: Donor health assessment following living-donor liver transplantation. Hepatology 30(4 Part 2): 172A
Schütt, G.R. 2000: Donor hospital development in Germany. Transplantation Proceedings 32(3): 587
Wilhelm, M.J.; Pratschke, J.; Paz, D.M.; Laskowski, I.A.; Mackenzie, H.S.; Hancock, W.W.; Tilney, N.L. 2001: Donor hypertension and recipient immune responsiveness in chronic rat cardiac allograft rejection. Transplantation Proceedings 33(1-2): 321-322
Yamani, M.H.; Starling, R.C.; Tuzcu, E.M.; Cook, D.J.; Abdo, A.; Paul, P.; Ratliff, N.B.; Yu, Y.; Mccarthy, P.M.; Young, J.B. 2003: Donor intracerebral hemorrhage is associated with upregulation of the vitronectin receptor. Circulation 108(17): IV331
Yamani, M.H.; Starling, R.C.; Tuzcu, E.M.; Haji, S.A.; Cook, D.J.; Abdo, A.S.; Ratliff, N.B.; Yousufuddin, M.M.; Mccarthy, P.M.; Young, J.B. 2003: Donor intracranial bleeding is associated with advanced transplant coronary vasculopathy Evidence from intravascular ultrasound. Journal of Heart and Lung Transplantation 22(1S): S76
Yamani, M.H.; Cook, D.J.; Abdo, A.S.; Yousufuddin, M.; Starling, R.C.; Yu, Y.; Tuzcu, E.M.; Ratliff, N.B.; Paul, P.; Mccarthy, P.M.; Young, J.B. 2003: Donor intracranial bleeding is associated with upregulation of the angiotensin receptor. Journal of Heart and Lung Transplantation 22(1S): S212
Mcneill, A.M.; Abdo, A.S.; Cook, D.J.; Starling, R.C.; Ratliff, N.B.; Mccarthy, P.M.; Young, J.B.; Yamani, M.H. 2003: Donor intracranial hemorrhage is associated with graft dysfunction and poorer survival following heart transplantation. Journal of Heart and Lung Transplantation 22(1S): S112-S113
Margolis, D.; Trost, B.; Garlie, N. 2000: Donor leukocyte infusions for AML Clinical observations, immunologic data and questions from a clinical case. Acta Haematologica (Basel) 103(Suppl 1): 57
Hildebrandt, G.C.; Corrion, L.A.; Olkiewicz, K.M.; Clouthier, S.G.; Liu, C.; Cooke, K.R. 2003: Donor leukocyte-production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation. Blood 102(11): 945a-946a
Freeman, R.B. 1999: Donor liver allocation: facts and fiction. Transplantation 68(7): 1066-1069
Chokshi, M.M.; Schmiedlin Ren, P.; Perrin, M.M.; Moseley, R.H.; Lown, K.S. 2001: Donor liver cytochrome P450 3A4 activity can be predicted with the 14C-erythromycin breath test in liver transplant patients. Gastroenterology 120(5 Suppl 1): A 561
Durakovic, N.; Bezak, K.B.; Huang, C.T.; Luznik, L. 2003: Donor lymphocyte infusion -derived T cell responses in vivo Differential fate of CD4+ and CD8+ T cells. Blood 102(11): 695a-696a
Barge, R.M.Y.; Marijt, E.W.A.; Osanto, S.; Starrenburg, I.; Smit, W.M.; Schaafsma, M.R.; Fibbe, W.E.; Falkenburg, J.H.F.; Willemze, R. 2003: Donor lymphocyte infusion 6 months after in vitro T-cell depleted non-myeloablative stem cell transplantation induces rapid conversion to full donor chimerism in patients with high risk malignancies. Blood 102(11): 969a
Roush, K.S.; Hillyer, C.D. 2002: Donor lymphocyte infusion therapy. Transfusion Medicine Reviews 16(2): 161-176
Peceny, R.; Elmaagacli, A.H.; Trenschel, R.; Ottinger, H.; Beelen, D.W. 2003: Donor lymphocyte infusions after transplantation of allogeneic, highly purified peripheral blood CD34+ cells in chronic myelogenous leukemia. Blood 102(11): 423b
Arnold, R.; Massenkeil, G.; Rosen, O.; Doerken, B.; Hoelzer, D. 2002: Donor lymphocyte infusions for prevention of relapse after stem cell transplantation in adults with high risk acute lymphoblastic leukemia. Experimental Hematology (Charlottesville) 30(6 Suppl 1): 134
Kolb, H.J.; Schmid, C.; Schleuning, M.; Stoetzer, O.; Ledderose, G.; Hiddemann, W.; Multhoff, G. 2001: Donor lymphocyte transfusions in acute leukemia. Annals of Hematology 80(Suppl 2): S14
Korbling, M.; Khouri, I.; Giralt, S.; Champlin, R. 2000: Donor lymphocytes for cellular immunotherapy Impact of G-CSF on lymphoid subsets and CD34+ cells. Vox Sanguinis 78(Suppl 1): O122
Kerman, R.; Gibson, H.; Van Buren, C.; Sahai, R.; Garcia, C.; Mckissick, E.; Olivarez, C.; Knight, R.; Katz, S.; Kahan, B. 2002: Donor mismatching, transplant and graft loss result in similar recipient sensitization not affecting retransplant graft survival. Tissue Antigens 59(2 Suppl): 111
Beavers, K.L.; Fair, J.H.; Sandler, R.S.; Shrestha, R. 2001: Donor morbidity associated with living donor liver transplantation. Gastroenterology 120(5 Suppl 1): A 26
Beavers, K.L.; Sandler, R.S.; Shrestha, R. 2002: Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 8(2): 110-117
Kasiske, B.L.; Koushik, R.; Humar, A.; Matas, A. 2003: Donor muscle mass and recipient nehron dose can be used to estimate serum creatinine after transplantation. Journal of the American Society of Nephrology 14(Abstracts Issue): 438A
Cerny, S.; Pavel, P.; Pirk, J.; Hola, I.; Brezina, A.; Sedlacek, J.; Straka, F.; Hegarova, M.; Malek, I. 2002: Donor myocardial protection using secondary blood cardioplegia during heart transplantation Prospective randomized study in 100 patients. Journal of Heart and Lung Transplantation 21(1): 61-62
Zhou, Q.; Baqir, S.; Brochard, V.; Smith, L.C.; Renard, J.P.ul 2002: Donor nuclei are not well reprogrammed by nuclear transfer procedure. Biology of Reproduction 66(Suppl 1): 237-238
Verschuuren, E.A..; Popa, E.R..; Van Der Bij, W.; Harmsen, M.C..; The, T.H..; Hepkema, B. 2001: Donor or recipient origin of post transplant lymphoproliferative disease after lung transplantation. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 20(2): 199
Muti, G.; Mancini, V.; Veronese, S.; Poli, F.; Oreste, P.; Baldanti, F.; Rondinara, G.; Alberti, A.; Uziel, L.D.; Caramella, M.; Morra, E. 2003: Donor or recipient origin of posttransplant lymphoproliferative disorders in liver transplanted patients Two different, clinically relevant, patterns of disease. Blood 102(11): 629a-630a
Pascher, A.; Sauer, I.M.; Mueller, A.R.; Walter, M.; Settmacher, U.; Steinmueller, T.; Neuhaus, P. 2001: Donor policy and outcome in adult-to-adult right lobe living donation liver transplantation. Hepatology 34(4 Pt 2): 245A
Allain, J.P.; Sarkodie, F.; Anokwa, M.; Owusu Ofori, S.; Opare Sem, O. 2002: Donor pre-donation screening for HBV, HIV and HCV in Ghana. Vox Sanguinis 83(Suppl 2): 228
Sudarshan, C.D.; Orr, H.; Clark, S.C.; Roughan, J.; Flecknell, P.; Dark, J.H. 1999: Donor pre-treatment with inhaled nitric oxide attenuates acute lung injury following single lung transplantation. Journal of Heart and Lung Transplantation 18(1): 78
Cozzi, E.; Seveso, M.; Baldan, N.; De Benedictis, G.M.; Busetto, R.; Cadrobbi, R.; Calabrese, F.; Carraro, P.; Ravarotto, L.; Ferrari, V.; Castagnaro, M.; Bernardini, D.; Lavitrano, M.L.; Bach, F.H.; Ancona, E. 2003: Donor preconditioning with carbon monoxide in pig-to-primate xenotransplantation. Xenotransplantation 10(5): 528
Schnuelle, P.; Yard, B.A.; Braun, C.; Dominguez, E.; Schaub, M.; Sturm, J.; Post, S.; Van Der Woude, F.J. 2002: Donor preconditioning with dopamine substantially improves initial graft function after kidney transplantation. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 189A
Reutzel-Selke, A.; Tullius, S.G.; Zschockelt, T.; Nieminen-Kelhä, M.; Bachmann, U.; Jonas, S.; Pratschke, J.; Schmidbauer, G.; Bechstein, W.O.; Volk, H.; Neuhaus, P. 2001: Donor pretreatment of grafts from marginal donors improves long-term graft outcome. Transplantation Proceedings 33(1-2): 970-971
Wittwer, T.; Franke, U.F.W.; Sandhaus, T.; Schuette, A.; Richter, S.; Albes, J.M.; Mueller, T.; Schubert, H.; Wahlers, T. 2003: Donor pretreatment using the aerosolized prostacyclin analogue Iloprost optimizes postischemic function of non heart beating donor lungs. Journal of Heart and Lung Transplantation 22(1S): S117
Sakagawa, T.; Kiyochi, H.; Honda, K.; Kobayashi, N. 2002: Donor pretreatment with FTY720 increases graft lymphocytes but does not affect graft survival following rat small bowel transplantation. Transplantation Proceedings 34(3): 973-974
Buscaroli, A.; Stipo, L.; De Sanctis, L.B.; Manna, C.; Bertuzzi, V.; Orlandi, V.; Iannelli, S.; Scolari, M.P.; Stefoni, S. 1999: Donor quality and kidney transplant outcome A retrospective analysis. Nephrology Dialysis Transplantation 14(9): A291
Simpson, M.A.; Pomposelli, J.J.; Gordon, F.D.; Lewis, W.D.; Jenkins, R.L.; Nixon, A.M.; Richman, E.; Pomfret, E.A. 2003: Donor quality of life after live donor adult liver transplantation. Hepatology 38(4 Suppl 1): 656A
Lafferty, M.T.; Lowe, R.; Litty, C.A.; Lugo, F.F. 1999: Donor re-entryThe efficacy of the process. Transfusion 39(10 Suppl): 33S
Kleinman, S.H.; Williams, A.E.; Busch, M.P.; Wu, Y. 1999: Donor reactions to notification of abnormal test results. Transfusion 39(10 Suppl): 113S
Amoah, J.; Boye, M.A.jei 2002: Donor recruitment and selection, problems in developing countries A test case in Ghana. Vox Sanguinis 83(Suppl 2): 46
Elfath, M.; Mcneil, D.; Whitley, P.; Sawyer, S. 1999: Donor red cell volume and blood iron recovery after two-unit red cell donation. Transfusion 39(10 Suppl): 29S
Gäbel, H. 2003: Donor registries throughout Europe and their influence on organ donation. Transplantation Proceedings 35(3): 997-998
Snyder, E.; Baril, L.; Dincecco, D.; Wu, Y.Y.; Brantigan, B.; Elfath, D. 2002: Donor safety and physiologic response to automated collection of two units of RBC on the Alyx component collection system. Vox Sanguinis 83(Suppl 2): 234
Basaran, O.; Karakayali, H.; Emiroğlu, R.; Tezel, E.; Moray, G.; Haberal, M. 2003: Donor safety and quality of life after left hepatic lobe donation in living-donor liver transplantation. Transplantation Proceedings 35(7): 2768-2769
Zeytunlu, M.; Icoz, G.; Kiliç, M.; Demirbas, T.; Tokat, Y.; Yuzer, Y. 2003: Donor safety in adult-to-adult living donor liver transplantation. Transplantation Proceedings 35(4): 1430-1432
Kim, D.G.; Na, S.E.; Chung, E.S.; Moon, I.S.; Lee, M.D.; Kim, I.C. 2003: Donor safety in living donor liver transplantation using the right lobe. Transplantation Proceedings 35(1): 53-54
Solaz, N.N.; Kemahli, S.; Cin, S. 2002: Donor satisfaction in blood bank and future donations. Vox Sanguinis 83(Suppl 2): 36
Niedhart, C.; Pingsmann, A.; Juergens, C.; Marr, A.; Blatt, R.; Niethard, F.U. 2003: Donor site morbidity after bone graft harvesting from the ventral and dorsal iliac crest A prospective, controlled study. Zeitschrift fuer Orthopaedie und ihre Grenzgebiete 141(4): 481-486
Aikawa, A.; Hadano, T.; Ohara, T.; Yamashita, M.; Arai, K.; Hirayama, N.; Mori, Y.; Muramatsu, M.; Hasegawa, A. 2001: Donor specific antibody suppression in ABO incompatible kidney transplantation. Transplantation Proceedings 33(1-2): 395-397
Baan, C.C.; Balk, A.H.M.M.; Van Der Mast, B.J.; Van Den Engel, S.; Maat, A.P.; Weimar, W. 2004: Donor specific cytotoxic non-responsiveness long after clinical heart transplantation. Journal of Heart and Lung Transplantation 23(2S): S46-S47
Ishido, N.; Matsuoka, J.; Fujiwara, T.; Tanaka, S.; Matsuno, T.; Tanaka, N. 1999: Donor specific hyporesponsiveness in a clinically tolerant renal transplant recipient. Transplantation Proceedings 31(7): 2880-2882
Goldstein, D.R.; Chang, T.; Sweeney, S.D.; Kirklin, J.K.; Thomas, J.M.; George, J.F. 1999: Donor specific spleen cells mediate allograft survival by a different mechanism that bone marrow. Journal of Heart and Lung Transplantation 18(1): 69
Kong, J.M.; Jung, J.H.; Sung, I.K.; Jung, J.S. 2000: Donor specific transfusion for living donor kidney transplantation Single center experience. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 696A
Dulkys, Y.; Escher, S.E.; Elsner, J. 2004: Donor to donor variation of the chemokine receptor CCR1 on human eosinophils and its prolonged internalization by RANTES. Journal of Allergy and Clinical Immunology 113(2 Suppl): S167
Palese, M.A.; Colonna, J.O.; Chai, T.C. 2003: Donor to native ureteroureterostomy in a patient with pre-existing ileal conduit during renal transplantation. Urology 61(3): 643
Schmidbauer, G.S.; Kuenzel, J.S.; Homeyer, A.; Schwemmle, K. 2002: Donor treatment improves survival of rat cardiac allografts in sensitized recipients. Transplantation Proceedings 34(5): 1477-1478
Schmidbauer, G.; Kuenzel, J.S.; Homeyer, A.; Schwemmle, K. 2002: Donor treatment prolongs survival of rat cardiac allografts in sensitized rat recipients. Transplantation Proceedings 34(7): 2897-2898
Morris, E.S.; Macdonald, K.P.; Rowe, V.; Johnson, D.H.; Banovic, T.; Clouston, A.D.; Hill, G.R. 2003: Donor treatment with peg-G-CSF induces profound transplant tolerance due to the generation of IL-10 producing regulatory T cells. Blood 102(11): 945a
Mcgee, E.; Mccarthy, P.M.; Hoercher, K.J.; Garnreiter, J.; Banbury, M.K.; Navia, J.L.; Feng, J.; Blackstone, E.H. 2004: Donor tricuspid annuloplasty reduces post-transplant tricuspid regurgitation. Journal of Heart and Lung Transplantation 23(2S): S49
Chiavetta, J.A.; Sammon, A.K.; Sher, G.D.; Newman, A.M.; Ennis, M.; Gula, C.A. 2000: Donor understanding and validity of health screening questions regarding travel to countries endemic for bovine spongiform encephalopathy. Vox Sanguinis 78(Suppl 1): P344
Michalek, J.; Collins, R.H.; Durrani, H.P.; Douek, D.C.; Vitetta, E.S. 2002: Donor-Derived Alloreactive T Cell Clones and Anti-Leukemia T Cell Clones Can Be Different. Blood 100(11): Abstract No. 5212
Zhang, X.; Schon, C.N.; Maziarz, R.T.; Streeter, P.R. 2002: Donor-Derived CD4+134+ 25+ T Cells from Animals with Acute Graft-Versus-Host Disease Differentially Regulate T Cell Immune Responses. Blood 100(11): Abstract No. 3256
Montagna, D.; Maccario, R.; Maserati, E.; Montini, E.; Bonetti, F.; Giorgiani, G.; Destefano, P.; Moretta, A.; Lisini, D.; Pasquali, F.; Locatelli, F. 2002: Donor-Derived, but Not Recipient-Derived, Dendritic Cells Pulsed with JMML Cells Are Able To Generate Long-Term, Leukemia- Specific CTL Lines. Blood 100(11): Abstract No. 1451
Gandy, K.L.; Chao, N.J.; Long, G.D.; Sartain, V.; Seigler, H.F.; Rizzieri, D.A. 2002: Donor-Specific Tolerance after Hematopoietic Reconstitution with Campath-1H Treated Mobilized Peripheral Blood Cells in a Sublethal Preconditioning Regimen. Blood 100(11): Abstract No. 1592
Essington, T.E.; Hansson, S. 2002: Donor-control, Lotka-Volterra, and the functional response of baltic sea cod. Ecological Society of America Annual Meeting Abstracts 87: 123
Asavaroengchai, W.; Bronson, R.T.; Sykes, M.; Yang, Y.G.ang 2003: Donor-derived IFN-gamma inhibits GVHD in mice after CD4-depleted allogeneic hematopoietic cell transplantation An essential role for IFN-gamma in controlling donor CD8 T cell activation, proliferation, and survival. Blood 102(11): 949a
Yamamoto, S. 2003: Donor-derived TNF-alpha can suppress Th1-dependent CTL generation during acute GVHD in mice. Hokkaido Journal of Medical Science 78(5): 429-436
Mueller, N.J.; Weisser, M.; Fehr, T.; Wüthrich, R.P.; Müllhaupt, B.; Lehmann, R.; Imhof, A.; Aubert, J.-D.; Genoni, M.; Kunz, R.; Weber, M.; Steiger, J. 2010: Donor-derived aspergillosis from use of a solid organ recipient as a multiorgan donor. Transplant Infectious Disease: An Official Journal of the Transplantation Society 12(1): 54-59
Lee, W.; Lu, L.; Chiang, Y.; Wang, H.; Jeng, L.; Huang, C.; Chen, M.; Qian, S. 2001: Donor-derived costimulatory molecule-deficient dendritic cells impair the allostimulatory function of recipients' antigen-presenting cells. Transplantation Proceedings 33(1-2): 273
Juliusson, G.; Malm, C.; Karlsson, K.; Backstrom, G. 2003: Donor-derived epithelial cells in buccal mucosa smears following allogeneic hematopoietic stem cell transplantation in 54 patients Usually mixed chimerism, but level not related to procedure, time after transplantation, or graft-versus-host disease. Blood 102(11): 155b
Sheil, A.G. 2001: Donor-derived malignancy in organ transplant recipients. Transplantation Proceedings 33(1-2): 1827-1829
Warnecke, G.; Faendrich, F.; Sommer, S.P.; Steinkamp, T.; Zehle, G.; Ruhnke, M.; Simon, A.R.; Hohlfeld, J.M.; Niedermeyer, J.; Haverich, A.; Strueber, M. 2003: Donor-derived suppressor macrophages for recipient-specific immunosuppression in lung transplantation in minipigs. Journal of Heart and Lung Transplantation 22(1S): S81-S82
Prieto, M.; Nicolas, D.; Rayon, J.M.; Berenguer, M.; Carrasco, D.; Mir, J.; Berenguer, J. 2000: Donor-recipient HLA matching does not predict accelerated progression of hepatitis C following liver transplantation in genotype 1b infection. Hepatology 32(4 Pt 2): 261A
He, J.Q.; Nelson, K.; Carithers, R.L.J.; Larson, A.M.; Parkins, J.D.; Gaur, L.K. 2003: Donor-recipient sharing of HLA class II alleles predicts earlier recurrence of HCV following liver transplantation. Human Immunology 64(Suppl 1): S69
Borozdenkova, S.; Cormer, A.; Ilynsky, I. 1999: Donor-specific HLA antibodies in cardiac allograft recipients. Human Immunology 60(Suppl 1): S85
Martin, L.; Guignier, F.; Mousson, C.; Rageot, D.; Justrabo, E.; Rifle, G. 2001: Donor-specific HLA antibodies in eluates from renal transplants with Chronic Allograft Nephropathy. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 939A
Tambur, A.R.; Ben Ari, Z.; Herrera, N.D.; Heeger, P.; Klein, T.; Micowitz, R.; Mor, E. 2003: Donor-specific IFN-gamma producing lymphocytes profile in hepatitis+ liver recipients. Human Immunology 64(Suppl 1): S47
Van Der Mast, B.J.; Van Besouw, N.M.; De Kuiper, R.; Vaessen, L.M.B.; Smak Gregoor, P.J.H.; Jzermans, J.N.M.I.; Van Gelder, T.; Weimar, W. 1999: Donor-specific T-cell reactivity can identify transplant patients in whom immunosuppressive therapy can be drastically and safely reduced. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 750A
Van Besouw, Nicole M.; Van Der Mast, Barbara J.; De Kuiper, Ronella; Vaessen, Lenard M.B.; Gregoor, Peter J.H. Smak; Ijzermans, Jan N.M.; Van Gelder, Teun; Weimar, Willem 2000: Donor-specific T-cell reactivity identifies patients in whom the immunosuppressive load can be safely reduced. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 710A
Shimizu, Y.; Otomo, N.; Yu, S.; Margenthaler, J.A.; Flye, M.W. 2001: Donor-specific antigen transfusion-mediated cardiac allograft tolerance is prevented by prior treatment with anti-CD8, but not anti-CD4, antibody. Transplantation Proceedings 33(1-2): 150-151
Inuzuka, S.; Koga, S.; Nishikido, M.; Miyata, Y.; Kanda, S.; Saito, Y.; Kanetake, H. 2002: Donor-specific blood transfusion prolongs cardiac allograft survival in rats The role of nitric oxide and prostaglandin E2. International Journal of Molecular Medicine 10(Suppl 1): S47
Van Der Mast, Barbara J.; Van Besouw, Nicole M.; De Kuiper, P.; Feyens, L.A. De Vries; Vaessen, L.M.B.; Gregoor, P.J.H. Smak; Ijzermans, J.N.M.; Baan, C.C.; Van Gelder, T.; Weimar, W. 2001: Donor-specific cytotoxic T-cell reactivity as a tool to identify kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 870A
Welters, M.; Oei, F.; Knoop, C.; Vaessen, L.; Wassenaar, C.; Claas, F.; Bogers, A.; Weimar, W. 1999: Donor-specific high avidity cytotoxic T-lymphocytes induced by implantation of cryopreserved human cardiac valves. Journal of Heart and Lung Transplantation 18(1): 53
Gallagher, M.; Pei, J.; Youngs, D.; Hamilton, K.; Yadock, W.; Dieterich, S.; Lagasca, R.; Mickelson, E.; Marsh, C.; Hansen, J.; Nelson, K. 2002: Donor-specific hyporesponsiveness measured by CTLp and CFSE dye dilution. Human Immunology 63(Suppl 1): S22
Rogers, N.J.; Mirenda, V.; Jackson, I.; Dorling, A.; Lechler, R.I. 2000: Donor-specific inhibition of xenoreactive T cells in vitro and in vivo. Immunology 101(Suppl 1): 10
Morin, N.; Lamoureux, E.; Lipman, M.; Tector, J.; Tchervenkov, J.I.; Metrakos, P. 2000: Donor-specific portal transfusion augments microchimerism in a porcine model of small bowel transplantation. Transplantation Proceedings 32(6): 1290-1291
Van Der Mast, B.J.; Van Besouw, N.M.; De Kuiper, P.; Vaessen, L.M.B.; Smak Gregoor, P.J.H.; Ijzermans, J.N.M.; Van Gelder, T.; Weimar, W. 1999: Donor-specific pre-transplant T-cell reactivity predicts acute rejection after kidney transplantation. Human Immunology 60(Suppl 1): S101
Mohler, K.; Burnette, A.; Matas, A.; Reinsmoen, N. 2002: Donor-specific single cell detection of IFN- production identifies renal recipients at high risk for early acute rejection. Human Immunology 63(Suppl 1): S24
Van Pel, M.; Van Breugel, D.W.J.G.; Vos, W.; Kuis, W.; Boog, C.J.P. 2002: Donor-specific tolerance Result of extrathymic clonal deletion in a murine model?. European Journal of Immunogenetics 29(2): 123
Li, H.; Inverardi, L.; Molano, R.D.; Pileggi, A.; Knapp, J.; Kong, S.; Ricordi, C. 2001: Donor-specific tolerance to sequential or simultaneous islet allografts following minimal radiation based non-lethal conditioning and donor bone marrow infusions. Cell Transplantation 10(6): 523
Lezaic, V.; Jovicic, S.; Simic, S.; Blagojevic, R.; Stolic, I.; Simonovic, R.; Djukanovic, L. 2002: Donor-specific transfusion and renal allograft outcome. Nephron 92(1): 246-247
Grauhan, O.; Pazurek, J.; Lehmkuhl, H.; Hummel, M.; Pasic, M.; Weng, Y.G.; Hetzer, R. 2002: Donor-transmitted coronary atherosclerosis. Journal of Heart and Lung Transplantation 21(1): 62-63
Grauhan, O.; Meyer, R.; Hiemann, N.; Knosalla, C.; Lehmkuhl, H.; Dandel, M.; Pasic, M.; Weng, Y.; Hetzer, R. 2004: Donor-transmitted coronary atherosclerosis and cardiac allograft microvasculopathy. Journal of Heart and Lung Transplantation 23(2S): S157
Edelstein, J.; Jones, J.W.; Ren, X.; Ustuner, T.; Zdichavsky, M.; Perez-Abadia, G.; Granger, D.K.; Jevans, A.W.; Maldonado, C.; Breidenbach, W.; Barker, J.H.; Gruber, S.A. 2002: Donor/recipient skin and whole-blood cyclosporin a levels in a swine composite tissue allograft model: correlation and relationship to rejection. Transplantation Proceedings 34(4): 1315-1319
Mcneil, D.; Elfath, M.; Whitley, P.; Sawyer, S. 1999: Donors attitude towards the automation of blood component collection. Transfusion 39(10 Suppl): 147S
Ursula, P.; Ulrich, S.; Lanzer, G. 2004: Donors experiences of unrelated allogeneic bone marrow versus peripheral blood stem cell donation. Genes and Immunity 5(Suppl 1): S29
Niutta, E.; Maglionico, G.; Airaghi, C.; Belingheri, M.; Manfredi, G.; Amatruda, O.; Baratelli, L.; Fugazzola, C.; Gastaldi, L. 2001: Donors nephroangiosclerosis and transplantation outcome. Nephrology Dialysis Transplantation 16(6): A217
Dumler, F. 2000: Donors over age sixty in renal transplantation A single center clinical experience. Nephrology Dialysis Transplantation 15(9): A270
Fedorovskaya, E.A. 2000: Donors re-immunisation as a mean of increase of the stock of immune plasma. Vox Sanguinis 78(Suppl 1): P649
Srivastava, A.; Kumar, A.; Agarwal, A. 2003: Donors with renal cysts: a dilemma in decision making. Transplantation Proceedings 35(1): 30-31
Bowden, F.J.; Bright, A.; Rode, J.W.; Brewster, D. 2000: Donovanosis causing cervical lymphadenopathy in a five-month-old boy. Pediatric Infectious Disease Journal 19(2): 167-169
Gupta, S.; Kumar, B. 2002: Donovanosis in India: declining fast?. International Journal of Std and Aids 13(4): 277
Morrone, A.; Toma, L.; Franco, G.; Latini, O. 2003: Donovanosis in developed countries: neglected or misdiagnosed disease?. International Journal of Std and Aids 14(4): 288-289
Sege, Robert D.; Flanigan, Elizabeth; De Vos, Edward; Spivak, Howard 2003: Dont ask, do tell Parental expectations about violence prevention anticipatory guidance. Pediatric Research 53(4 Part 2): 196A
Corrigan, P.W. 2004: Don't call me nuts: an international perspective on the stigma of mental illness. Acta Psychiatrica Scandinavica 109(6): 403-404
Anderson, J. 1999: "Don't confuse me with facts...": evidence-based practice confronts reality. Medical Journal of Australia 170(10): 465-466
Eberl, M. 2002: Don't count your interleukins before they've hatched. Trends in Immunology 23(7): 341-342
Cotton, R.B. 2000: Don't discard your indomethacin yet. Acta Paediatrica 89(11): 1278-1279
Weinstock, M.A. 2001: Don't drop the Slop!. Photodermatology Photoimmunology and Photomedicine 17(5): 238-239
Collin, M. 2004: Dont forget about Streptococcus pyogenes 1329-1335. Microbes and Infection 6(3): 336
Mindell, D.P.; Villarreal, L.P. 2003: Don't forget about viruses. Science 302(5651): 1677
Collier, C. 2002: Don't forget the anterior subdural space!. Regional anesthesia and pain medicine 27(5): 536-7; author reply 537
Lutscher, F.; Lewis, M.A. 2003: Dont get lost in space. Ecological Society of America Annual Meeting Abstracts 88: 212-213
Lambert, H.P. 1999: Don't keep taking the tablets?. Lancet 354(9182): 943-945
Chawla, A.; Saez, E.; Evans, R.M. 2000: Don't know much bile-ology. Cell 103(1): 1-4
Frumkin, H. 2002: Don't lament, reinvent! the future of occupational medicine. American Journal of Industrial Medicine 42(6): 526-528
Klein, J.J.; Harper, M.A. 1999: Dont let your child get carried away 24 min video. Journal of Burn Care and Rehabilitation 20(1 Part 2): S162
Brown, D.R.. 2002: Don't lose sleep over prions: role of prion protein in sleep regulation. Neuroreport 13(1): A1
Hall, J.G. 2002: Don't use the term "amyoplasia" loosely. American Journal of Medical Genetics 111(3): 344
Bombois, S.; Maurage, C.A.; Lebert, F.; Pasquier, F.; Ruchoux, M.M. 2002: Dont we forget the vascular component of dementia?. Journal of the Neurological Sciences (203-204): 287
Crouthamel, B.J.; Sackett, G.P. 2002: Dont worry, if it itches, just scratch it. American Journal of Primatology 57(Suppl 1): 49
Hennessey, C.J. 2003: Donut maker. Official Gazette of the United States Patent and Trademark Office Patents 1266(3)
Anderson, B.O.; Reed, D.R.; Mann, G.N.; Austin Seymour, M.; Moe, R.E. 2003: Donut mastopexy lumpectomy An oncoplastic operation permitting breast preservation for large breast malignancies. Breast Cancer Research and Treatment 82(Suppl 1): S107
Penny, D.; Holmes, S. 2001: Doom01 Biological mathematics in evolutionary processes. Trends in Ecology and Evolution 16(6): 275-276
Llanes, J.N.; Kidwell, C.S.; Starkman, S.; Leary, M.C.; Eckstein, M.; Saver, J.L. 2001: Door-to-needle times in acute stroke clinical trials. Neurology 56(8 Suppl 3): A436
Matsunaga, J.; Kobayashi, N.; Matsunaga, N.; Hearing, V.J. 1999: Dopachrome and dopaminechrome cytotoxicity against murine melanoma and neuroblastoma cells. Pigment Cell Research (Suppl 7): 28
Pallis, E.; Thermos, K.; Spyraki, C. 2000: Dopamine - somatostatin interactions after antidepressant chronic treatment. European Journal of Neuroscience 12(Suppl 11): 468
Holtback, U.; Kruse, S.M.; Adashi, S.; Aperia, A.; Brismar, H. 2001: Dopamine 1 receptor recruitment is required for PKC signaling in renal tubular cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 592A
Clark, D.; Staddon, S.; Mata, I.; Mancama, D.; Arranz, M.J.; Kerwin, R.W. 2004: Dopamine 3 receptors genetic variants Influence in schizophrenia and antipsychotic response. European Neuropsychopharmacology 14(Suppl 1): S64-S65
Jay, T.ér.ès.M. 2003: Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Progress in Neurobiology 69(6): 375-390
Acquas, E.; Di Chiara, G. 2002: Dopamine Acetylcholine interactions. Di Chiara, Gaetano Handbook of Experimental Pharmacology Dopamine in the CNS II 85-115
Morelli, M.; Acquas, E.; Ongini, E. 2002: Dopamine Adenosine interactions. Di Chiara, Gaetano Handbook of Experimental Pharmacology Dopamine in the CNS II 135-150
Pierce, J.D.; Jegathesan, J.; Arnett, M.; Reed, G.; Masure, R.H.; Clancy, R.L. 2004: Dopamine Alleviation of Reactive Oxygen Species Mediated Diaphragm Fatigue. FASEB Journal 18(4-5): Abstract 702
Goodman, A.B. 2002: Dopamine B hydroxylase genotypes and recent linkage findings support vitamin A cascade genes as candidates in psychotic depression. American Journal of Medical Genetics 114(7): 762
Calabrese, E.J. 2001: Dopamine: biphasic dose responses. Critical Reviews in Toxicology 31(4-5): 563-583
Zeng, B.Y.; Heales, S.J.R.; Canevari, L.; Jenner, P. 2001: Dopamine D-1, D-2 and D-3 receptor binding density was not altered in tetrahydrobiopterin-deficient hph-1 mice. British Journal of Pharmacology 133(Proceedings Suppl): 158P
Li, N.; Wu, W.R.; Craft, R.M.; Sorg, B.A. 2000: Dopamine D1 receptor activation in the medial prefrontal cortex regulates the expression of cocaine sensitization. Drug and Alcohol Dependence 60(Suppl 1): S126-S127, 1 December
Matsumoto, K.; Andersson, K.E.; Hedlund, P. 2004: Dopamine D1 receptor agonist-induced erections in awake and freely moving rats. Journal of Urology 171(4 Suppl): 426
Matsushima, T.; Koga, K.; Izawa, E.I.; Yanagihara, S. 2000: Dopamine D1 receptor dependent long-term potentiation in basal ganglia of neonatal chicks. Neuroscience Research Suppl (24): S30
Matsushima, T.; Izawa, E.I.; Yanagihara, S.; Koga, K.; Csillag, A. 2000: Dopamine D1 receptor dependent long-term potentiation of excitatory synapses in lobus parolfactorius in quail chick. European Journal of Neuroscience 12(Suppl 11): 201
Haque, R.; Maltseva, O.; Ivanova, T.; Iuvone, P.M. 2000: Dopamine D1 receptor expression in cultured human and monkey retinal pigment epithelial cells. IOVS Investigative Ophthalmology and Visual Science 41(4): S843
Gabrielian, A.; Cooper, D.C.; Peterson, J.D.; Dracheva, S.; Sealfon, S.C.; White, F.J. 1999: Dopamine D1 receptor function and operant responding in transgenic mice overexpressing the D1 receptor in the prefrontal cortex. Society for Neuroscience Abstracts 25(1-2): 610
Newman, T.; Parker, C.; Barr, C.; Suomi, S.; Goldman, D.; Higley, D. 2003: Dopamine D1 receptor gene 5 UTR variation interacts with sex and rearing experience to influence alcohol consumption in rhesus macaques. American Journal of Primatology 60(Suppl 1): 134
Minei, R.; Wakakura, M.; Mashimo, K. 2003: Dopamine D1 receptor on cultured Muller cells. Kaneko, Akimichi The neural basis of early vision: 147
Cooper, D.C.; White, F.J. 1999: Dopamine D1 receptor signaling in the nucleus accumbens Relationship to cocaine-seeking behavior. Society for Neuroscience Abstracts 25(1-2): 1072
Vieira Coelho, M.A.; Soares, D.S.lva, P. 1999: Dopamine D1 receptors reduce jejunal electrolyte transport in young but not in adult rats. Clinical and Experimental Pharmacology and Physiology 26(Suppl ): S57
Trivedi, M.; Hussain, T.; Lokhandwala, M.F. 2002: Dopamine D1-like receptor recruitment in renal proximal tubules of Sprague Dawley rats. FASEB Journal 16(4): A197
Bek, M.J.; Reinhardt, H.C.; Fischer, K.G.; Pavenstaedt, H. 2001: Dopamine D1-like receptors regulate basolateral Na+/K+-ATPase activity and Ca2+ influx via the PKA R-I-beta subunit in a human proximal tubular cell line. Kidney and Blood Pressure Research 24(4-6): 245
Karlsson, P.; Farde, L.; Halldin, C.; Swahn, C.G.; Sedvall, G. 1999: Dopamine D1-receptor binding in neuroleptic naive schizophrenic patients examined by PET. Journal of Nuclear Medicine 40(5 Suppl): 30P
Newman Tancredi, A.; Brocco, M.; Cussac, D.; Rivet, J.M.; Chaput, C.; Touzard, M.; Millan, M.J. 1999: Dopamine D2 and D3 receptor-mediated G-protein activation in rat caudate nucleus is increased by a unilateral 6-hydroxydopamine lesion of the substantia nigra A -GTPgammaS autoradiography study. Society for Neuroscience Abstracts 25(1-2): 1458
Marshall, J.F.; Henry, B.L. 1999: Dopamine D2 antagonists induce Fos expression in globus pallidus by acting at non-striatal dopamine receptors. Society for Neuroscience Abstracts 25(1-2): 1654
Truong, J.G.; Rau, K.S.; Hanson, G.R.; Fleckenstein, A.E. 2003: Dopamine D2 receptor agonists increase vesicular monoamine transporter-2 function. FASEB Journal 17(4-5): Abstract 645
Costa Mallen, P.; Swanson, P.D.; Franklin, G.M.; Costa, L.G.; Smith Weller, T.; Checkoway, H. 1999: Dopamine D2 receptor and monoamine-oxidase B polymorphisms, tobacco smoking, and Parkinsons Disease. Society for Neuroscience Abstracts 25(1-2): 2115
Hitzemann, R.; Hitzemann, B.; Rivera, S.; Gatley, J.; Thanos, P. 2001: Dopamine D2 receptor binding and the number of dopamine neurons in the BXD RI series Relationships to alcohol phenotypes. Alcoholism Clinical and Experimental Research 25(5 Suppl A): 71A
Pivonello, R.; Ferone, D.; De Herder, W.W.; Kros, M.J.; Del Basso De Caro, L.; Cappabianca, P.; Lombardi, G.; Hofland, L.J.; Lamberts, S.W.J. 2000: Dopamine D2 receptor expression in corticotroph pituitary tumors Preliminary data of an immunohistochemical and ligand-binding study. Journal of Endocrinological Investigation 23(6 Suppl): 8
Kaiser, R.; Hofer, A.; Grapengiesser, A.; Gasser, T.; Roots, I.; Kupsch, A.; Brockmoeller, J. 2002: Dopamine D2 receptor gene polymorphisms and L-Dopa induced psychosis and dyskinesia in Parkinsons disease. American Journal of Medical Genetics 114(7): 815
Ryoji, O.; Tetsuya, O.; Yoshihiko, O.; Ai, Y.; Masayuki, K. 2001: Dopamine D2 receptor is involved in the mechanisms of renal dopamine production and sodium. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S354
Kessler, R.M.; Ansari, M.S.; Li, R.; Dawant, B.; Meltzer, H.Y. 2003: Dopamine D2 receptor levels in extrastriatal and striatal regions in schizophrenia. Journal of Nuclear Medicine 44(5 Suppl): 36P
Thanos, P.K.; Volkow, N.D.; Freimuth, P.; Hitzemann, B.; Umegaki, H.; Ikari, H.; Roth, G.; Ingram, D.K.; Hitzemann, R. 2000: Dopamine D2 receptor upregulation in the nucleus accumbens of the rat after treatment with a D2 adenovirus vector and its effects on alcohol abuse. Alcoholism Clinical and Experimental Research 24(5 Suppl): 122A
Priest, C.A.; Margolis, F.L.; Margolis, J.W.; Cummings, D.M.; Borrelli, E.; Puche, A.; Shipley, M.T. 1999: Dopamine D2 receptor-deficient mice exhibit decreased levels of tyrosine hydroxylase expression in the olfactory bulb. Society for Neuroscience Abstracts 25(1-2): 130
Rogue, P.J.; Krady, M.M. 2003: Dopamine D2 receptor-induced ERK translocation to the nucleus involves multiple pathways. Molecular and Cellular Proteomics 2(9): 715
Amano, T.; Matsubayashi, H.; Akbar, M.; Sasa, M. 1999: Dopamine D2 receptor-mediated hypersensitivity in VTA dopamine neurons following repeated methamphetamine treatment with the patch clamp method. Japanese Journal of Pharmacology 79(Suppl 1): 223P
Neve, K.A.; Buck, D.C.; Wang, C. 2004: Dopamine D2 receptor-mediated stimulation of mitogen-activated protein kinases by transactivation of receptor tyrosine kinases. FASEB Journal 18(4-5): Abstract 399
Yao, L.; Dohrman, D.P.; Jiang, Z.; Fan, P.; Gordon, A.S.; Diamond, I. 2002: Dopamine D2 receptors activate PKA translocation and gene activation via betagamma dimers Synergistic amplification by acute exposure to ethanol. Alcoholism Clinical and Experimental Research 26(5 Suppl): 10A
Yamaguchi, I.; Dalman, F.; Moffat, M.; Todd, R.D.; O'malley, K.L. 1999: Dopamine D2 receptors modulate dopamine synthesis and release in a mesencephalic model of autoreceptor function. Clinical and Experimental Pharmacology and Physiology 26(Suppl ): S60-S61
Mayfield, R.D.; Zahniser, N.R. 1999: Dopamine D2 receptors regulate dopamine transporter-mediated dopamine uptake into unclamped, but not voltage-clamped, Xenopus oocytes. Society for Neuroscience Abstracts 25(1-2): 164
Whyte, D.; Johnson, A.K. 2001: Dopamine D2 receptors regulate mesenteric and renal resistance in response to heat stress. FASEB Journal 15(4): A93
Narkar, V.A.; Hussain, T.; Lokhandwala, M.F. 2001: Dopamine D2-like receptor activation causes stimulation of Na+, K+, ATPase via tyrosine phosphorylation and recruitment of Na+, K+, ATPase alpha1 subunit in proximal tubules. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 598A
Spealman, R.D.; Kongsamut, S.; Wettstein, J.G.; Rowlett, J.K. 2002: Dopamine D2-like receptor mechanisms in the discriminative stimulus and relapse-inducing effects of cocaine Studies with selective D2, D3, and D4 antagonists. FASEB Journal 16(4): A194
Narkar, V.; Hussain, T.; Pedemonte, C.; Lokhandwala, M. 1999: Dopamine D2-like receptor stimulation causes activation of p44/42 MAP kinase and promotes mitogenesis in opossum kidney cells. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 498A
Bortolozzi, A.A.; Evangelista, D.D.ffard, A.; Duffard, R.O.; Antonelli, M.C. 2001: Dopamine D2-type receptors in brains of 2,4-dichloro-phenoxyacetic acid exposed rats. Cellular and Molecular Neurobiology 21(2): 130
Chu, J.; Xu, K.; Chu, T.C.ing 2003: Dopamine D2/D3 receptors in human retinal precursor cells. FASEB Journal 17(4-5): Abstract 392
Wang, Y.; Xu, R.; Sasaoka, T.; Sankoorikal, E.B. 2002: Dopamine D2L receptor knockout mouse provides a unique model system for studying the functions of D2L and D2S. Nagatsu, Toshiharu , Reprint Author, Nabeshima, Toshitaka, McCarty, Richard, Goldstein, David S Catecholamine research: From molecular insights to clinical medicine: 175-178
Chu, E.G.; Potter, D.E. 2000: Dopamine D3 receptor agonist as a novel antiglaucoma agent Mechanisms and sites of action. AAAS Annual Meeting and Science Innovation Exposition 166: A91, February 17-22
Staddon, S.; Arranz, M.J.; Mata, I.; Munro, J.; Osborne, S.; Collier, D.; Kerwin, R. 2002: Dopamine D3 receptor and improvement in positive symptoms of schizophrenia. American Journal of Medical Genetics 114(7): 873
Van Kampen, J.M.; Stoessl, A.J.n 1999: Dopamine D3 receptor antisense attenuates levodopa-induced behavioural sensitization in rats. Society for Neuroscience Abstracts 25(1-2): 336
Joyce, J.N. 2001: Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs. Pharmacology and Therapeutics 90(2-3): 231-259
Silverdale, M.A.; Millan, M.J.; Crossman, A.R.; Brotchie, J.M. 2002: Dopamine D3 receptor blockade, and not stimulation, is associated with anit-parkinsonian activity in the MPTP-lesioned, nonhuman primate model of Parkinson disease. Neurology 58(7 Suppl 3): A493-A494
Wong, D.F.; Gjedde, A. 2003: Dopamine D3 receptor density and occupancy determined with selective D3 inhibitor and raclopride PET. Journal of Nuclear Medicine 44(5 Suppl): 256P
Pettersson Fernholm, K.J.; Forsblom, C.M.; Perola, M.; Groop, P.H.nrik 2002: Dopamine D3 receptor gene is not associated with nephropathy in type 1 diabetes. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 247A
Eichhammer, P.; Albus, M.; Rohrmeier, T.; Wodarz, N.; Klein, H.E. 1999: Dopamine D3 receptor gene variants as a possible predictor of neuroleptic induced movement disorders. Society for Neuroscience Abstracts 25(1-2): 1468
Joyce, J. 2003: Dopamine D3 receptor in Parkinsons disease and schizophrenia. European Neuropsychopharmacology 13(Suppl 4): S169-S170
Robinet, P.M.; Bardo, M.T. 1999: Dopamine D3 receptor involvement in amphetamine-induced contralateral rotation following a 6-OHDA lesion of the medial forebrain bundle in rats. Society for Neuroscience Abstracts 25(1-2): 1821
Staddon, S.; Arranz, M.J.; Beperet, M.; Anney, R.; Buckland, P.; Mancama, D.; Munro, J.; Mata, I.; Kerwin, R.W. 2003: Dopamine D3 receptor polymorphisms and olanzapine response in a human isolate from Northern Spain. American Journal of Medical Genetics 122B(1): 126
Hagan, J.J. 2001: Dopamine D3 receptors Pharmacology and potential therapeutic applications. British Journal of Pharmacology 133(Proceedings Suppl): 271P
Ross, J.T.; Nader, S.H.; Moore, T.; Nader, M.A. 2002: Dopamine D3 receptors and cocaines reinforcing and discriminative stimulus effects in rhesus monkeys. FASEB Journal 16(4): A195
Luippold, G.; Piesch, C.; Muehlbauer, B. 2002: Dopamine D3 receptors are not involved in the pathogenesis of a genetic model of hypertension. Kidney and Blood Pressure Research 25(3): 173-174
Baladi, M.G.; Newman, A.H.; France, C.P. 2010: Dopamine D3 receptors mediate the discriminative stimulus effects of quinpirole in free-feeding rats. Journal of Pharmacology and Experimental Therapeutics 332(1): 308-315
Plato, C.F.; Cox, B.F.; Reinhart, G.A. 2003: Dopamine D3-receptor activation produces hyperfiltration in normal but not streptozotocin-Induced diabetic rats. FASEB Journal 17(4-5): Abstract 587
Luippold, G.; Hindler, K.; Kuester, E.; Osswald, H.; Muehlbauer, B. 2002: Dopamine D3-receptor gene expression in salt-dependent hypertension. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 1): R102
Wonodi, I.; Avila, M.T.; Hong, E.L.; Buchanan, R.W.; Stine, O.C.; Thaker, G.K. 2003: Dopamine D3-receptor gene variant and association with saccadic disinhibition in schizophrenia. American Journal of Medical Genetics 122B(1): 169-170
Muehlbauer, B.; Pech, B.; Lemaire, H.G.; Gross, G.; Luippold, G. 2001: Dopamine D3-receptors in the regulation of glomerular and tubular function. Kidney and Blood Pressure Research 24(4-6): 355
Zorn, S.H.; Sanner, M.A.; Fliri, A.F.; Seymour, P.A. 2003: Dopamine D4 ligands for the treatment of novelty-seeking disorders. Official Gazette of the United States Patent and Trademark Office Patents 1269(3)
Shin, R.M.; Masuda, M.; Miura, M.; Suzuki, T.; Aosaki, T. 2003: Dopamine D4 receptor activation inhibits IPSCs at striatopallidal synapses. Neuroscience Research Suppl (26): S116
Bookman, E.B.; Kittles, R.A. 2001: Dopamine D4 receptor and alcohol dependence in African Americans. Alcoholism Clinical and Experimental Research 25(5 Suppl A): 68A
D.L.ca, A.; Rizzardi, M.; Buccino, A.; Torrente, I.; Mangino, M.; Salvioli, G.P.; Alessandrini, R.; Dallapiccola, B.; Novelli, G. 2001: Dopamine D4 receptor and intensity of reaction trait during infancy. American Journal of Human Genetics 69(4 Suppl): 546
Tian, H.B.; Yin, D.Z.; Zhang, L.; Wang, L.H.; Zhang, C.F.; Wu, C.Y.; Wang, Y.X. 2003: Dopamine D4 receptor antagonist 3- fluorobenzyl-8-methoxy-1,2,3,4-tetrahydrochromeno. Journal of Labelled Compounds and Radiopharmaceuticals 46(Suppl 1): S366
Belliotti, T.R.; Blankley, C.J.; Kesten, S.R.; Wise, L.D.; Wustrow, D.J. 1999: Dopamine D4 receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1225(5)
Baldessarini, R.J.; Zhang, K.; Tarazi, F.I. 2004: Dopamine D4 receptor antagonists as treatment for attention deficit-hyperactivity disorder. Official Gazette of the United States Patent and Trademark Office Patents 1283(2)
Thanos,P.K.; Habibi,R.; Michaelides,M.; Patel,U.B.; Suchland,K.; Anderson,B.J.; Robinson,J.K.; Wang,G.J.; Grandy,D.K.; Volkow,N.D. 2010: Dopamine D4 receptor deletion in mice does not affect operant responding for food or cocaine. Behavioural Brain Research 7(2): 508-511
D.L.ca, A.; Torrente, I.; Mangino, M.; Capon, F.; Rizzardi, M.; Salvioli, G.P.; Alessandroni, R.; Novelli, G.; Dallapiccola, B. 2000: Dopamine D4 receptor in the determination of infant temperament. American Journal of Medical Genetics 96(4): 555
Pollak, A.; Dunn Dufault, R.; Roe, D. 1999: Dopamine D4 receptor ligands. Official Gazette of the United States Patent and Trademark Office Patents 1228(1)
Civelli, O. 2002: Dopamine D4 receptors Molecular biology and pharmacology. Di Chiara, Gaetano Handbook of Experimental Pharmacology Dopamine in the CNS I 223-233
Tarazi, F.I.; Zhang, K.; Davids, E.; Baldessarini, R.J. 2003: Dopamine D4 receptors and ADHD New genetic linkage, novel pharmacotherapeutic target. Journal of Neurochemistry 87(Suppl 1): 66
D.B.uin, J.P.C.; Feenstra, M.G.P.; Hoornweg, R.; Joosten, R.N.J.M.A. 2000: Dopamine D4 receptors in the medial prefrontal cortex of the rat are involved in behavioural flexibility. European Journal of Neuroscience 12(Suppl 11): 174
Man, H.Y.; Liu, F.; Wan, O.; Becker, L.; Niznik, H.B.; Wang, Y.T. 1999: Dopamine D5 receptors bind to and regulate plasma membrane expression of GABAA receptors. Society for Neuroscience Abstracts 25(1-2): 1483
Gutierrez, A.; Martin, R.; Penafiel, A.; Rivera, A.; Khan, Z.U.; De La Calle, A. 1999: Dopamine D5 receptors in the rat substantia nigra. Society for Neuroscience Abstracts 25(1-2): 1219
Chesselet, M.F. 2002: Dopamine GABA interactions. Di Chiara, Gaetano Handbook of Experimental Pharmacology Dopamine in the CNS II 151-172
Robbins, T.W.; Everitt, B.J. 2002: Dopamine Its role in behaviour and cognition in experimental animals and humans. Di Chiara, Gaetano Handbook of Experimental Pharmacology Dopamine in the CNS II 173-211
Bailey, J.M. 2000: Dopamine: one size does not fit all. Anesthesiology 92(2): 303-305
Ajjimaporn, A.; Sharma, S.; Mannum, S.; Ward, S.; Eken, J.; Ebadi, M. 2004: Dopamine Transporter Disfunction in Weaver Mutant Mouse Brain. FASEB Journal 18(4-5): Abstract 162
Katz, J.L.; Moulden, E.; Newman, A.H. 2004: Dopamine Uptake Inhibitors Self-Administration and Effects on Cocaine. FASEB Journal 18(4-5): Abstract 161
Pollock, E.L.; Cunningham, J.R.; Neal, M.J. 2000: Dopamine acting at D4 receptors modulates nitric oxide release in the rabbit retina. British Journal of Pharmacology 131(Proceedings Suppl): 43P
Hu, M.C.; Fan, L.; Moe, O. 2000: Dopamine acutely stimulates dynamin-dependent NHE3 endocytosis. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 5A
Tanaka, Y.taka; Albert, Martin, L.; Hujita, Kouji; Takashima, Mayumi; Aketa, Shozo; Yokoyama, Eriko; Nonaka, Chieko; Koyama, Yoko; Takeshita, Masami 2000: Dopamine agonist improves speech output in nonfluent aphasia. Neurology 54(7 Supp 3): A102
Clarke, C.E.; Guttman, M. 2002: Dopamine agonist monotherapy in Parkinson's disease. Lancet 360(9347): 1767-1769
Undie, A.S.; Panchalingam, S. 2002: Dopamine agonist selectivity and physicochemical modulation of efficacy in stimulating GTPgammaS binding. FASEB Journal 16(4): A578
Zhang, Y.; Jetton, T.L. 1999: Dopamine agonist treatment reduces liver adiposity and very low density lipoprotein secretion rate in ob/ob mice. Diabetes 48(Suppl 1): A268
Woodman, M.; Martin Iverson, M.T. 2003: Dopamine agonist-induced reductions in prepulse inhibition of the acoustic startle response are not modulated by a type II corticosteroid agonist. Journal of Psychopharmacology 17(Suppl 3): A19
Liang, Y.; Castro, S.; Cincotta, A.H. 1999: Dopamine agonists ameliorate sympathetic regulation of glucagon release in ob/ob mice. Diabetes 48(Suppl 1): A200
Marek, K.; Jennings, D.; Seibyl, J. 2003: Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studies. Annals of Neurology 53(Suppl 3): S160
Kujawa, K.A.; Leurgans, S.; Raman, R.; Goetz, C.G. 1999: Dopamine agonists and orthostatic hypotension in Parkinsons disease. Neurology 52(6 Suppl 2): A407
Tanaka, K.I.; Fujita, N.; Asanuma, M.; Ogawa, N. 2003: Dopamine agonists prevent levodopa-induced abnormal increase of lipid peroxidation in 6-OHDA-lesioned mice. Journal of Pharmacological Sciences 91(Suppl I): 74P
Oertel, W.H.; Spieker, S.; Odin, P. 2000: Dopamine agonists therapy. European Journal of Neurology 7(Suppl 3): 163-164
Hablitz, J.J.; Gonzalez Islas, C. 2002: Dopamine alters threshold for initiation of epilptiform activity in rat neocortex. Epilepsia 43(Suppl 7): 129
Shashoua, V.E. 2000: Dopamine analog amide. Official Gazette of the United States Patent and Trademark Office Patents 1237(4)
Hipskind, R.A.; Esteban, I.V.cario 2000: Dopamine and 3-nitroproprionic acid induce apoptosis in neuroblastoma cells through pathways differentially sensitive to inhibitors of the p38 and ERK signaling cascades. European Journal of Neuroscience 12(Suppl 11): 61
Hokoc, J.N.; Faria, A.C.; Rehen, S.K.; Guimaraes, M.Z.P.; De Mello, F.G. 2000: Dopamine and L-Dopa inhibit DNA synthesis in neuroblast-like cells from chick embryo retina. IOVS Investigative Ophthalmology and Visual Science 41(4): S846
Havemann Reinecke, Ursula 2003: Dopamine and addiction Role in drive, motivation and therapy. Polish Journal of Pharmacology 55(3): 490
Aldridge, J.W.; Berridge, K.C. 1999: Dopamine and aging Control of the amount of grooming and stereotype of sequential patterns. Society for Neuroscience Abstracts 25(1-2): 808
O'donnell, Patricio 2003: Dopamine and ensemble coding in the striatum and nucleus accumbens A coincidence detection mechanism. Graybiel, Ann M , Reprint Author, DeLong, Mahlon R, Kitai, Stephen T The basal ganglia VI: 237-244
Glavin, G.B. 1999: Dopamine and gastroprotection. Clinical and Experimental Pharmacology and Physiology 26(Suppl ): S70
Nestler, E.J. 2002: Dopamine and gene expression. Di Chiara, Gaetano Handbook of Experimental Pharmacology Dopamine in the CNS I 321-337
Kuhn, D.M. 2002: Dopamine and its modulation of drug-induced neuronal damage. Massaro Edward J , Reprint Author Handbook of Neurotoxicology 2: 175-197
Mingote, S.M.; Feenstra, M.G.P.; De Bruin, J.P.C. 2000: Dopamine and noradrenaline release in the prefrontal cortex in relation to appetitive classical conditioning Importance of motivational state. European Journal of Neuroscience 12(Suppl 11): 95
Lederer, E.D.; Khundmiri, S.J. 1999: Dopamine and parathyroid hormone inhibit Na-K ATPase activity by different mechanisms in opossum kidney cells. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 456A
Nejsum, L.N.; Zelenina, M.; Aperia, A.; Froekiaer, J.; Nielsen, S. 2003: Dopamine and prostaglandin stimulation and protein kinase A inhibition mediates AQP2 endocytosis in cell culture independent of AQP2 Ser256 dephosphorylation. Journal of the American Society of Nephrology 14(Abstracts Issue): 310A
Yatin, S.M.; Miller, G.M.; Madras, B.K. 2002: Dopamine and psychostimulants induce c-Fos in cells expressing the dopamine transporter Potential mechanisms and relevance to presynaptic neuroadaptation. Drug and Alcohol Dependence 66(Suppl 1): S199
Zhou, D.; Zhou, R.; Hu, X.; Zhang, X.; Fan, J.; Wei, F.; Shen, Y. 2001: Dopamine and related factors in schizophrenia and other psychoses Recent molecular genetics studies in China. Bolis, C Liana , Pani, Luca , Licinio, Julio Dopaminergic system: Evolution from biological to clinical aspects 155-162
D.Chiara, G. 2002: Dopamine and reward. Di Chiara, Gaetano Author Handbook of Experimental Pharmacology Dopamine in the CNS II 265-319
Olazabal, D.E.; Rosenblatt, J.S.; Morrell, J.I. 2001: Dopamine and serotonin content and metabolism in the circuit supporting maternal behavior in rats. Hormones and Behavior 39(4): 342
Ribelayga, C.; Mangel, S.C. 2001: Dopamine and serotonin levels and release are controlled both by light and a circadian clock in the goldfish retina. IOVS Investigative Ophthalmology and Visual Science 42(4): S371
Rajewski, A.; Adamczewska Goncarzewicz, Z.; Dorszewska, J.; Rajewska, J. 2000: Dopamine and serotonin plasma blood level in adolescents with schizophrenia during perphenazine therapy. European Neuropsychopharmacology 10(Suppl 3): S322
Golimbet, V.E.; Manandyan, K.K.; Aksenova, M.G.; Kozlova, I.A.; Abramova, L.I.; Kaleda, V.G.; Oleichik, I.V.; Yurov, Y.B.; Nosikov, V.V.; Trubnikov, V.I. 2000: Dopamine and serotonin system gene polymorphisms in early age of onset schizophrenia. American Journal of Medical Genetics 96(4): 526-527
Kung, H.; Meegalla, S.; Kung, M.P.ng 1999: Dopamine and serotonin transporter ligands and imaging agents. Official Gazette of the United States Patent and Trademark Office Patents 1228(2)
Shabanov, P.D.; Lebedev, A.A.; Lebedev, V.A.; Gurkovskaya, O.V. 2000: Dopamine and stress hormones Mechanisms of reinforcement in rats reared in social isolation. Neuropsychopharmacology 23(S2): S148
Nieoullon, A.é 2002: Dopamine and the regulation of cognition and attention. Progress in Neurobiology 67(1): 53-83
Coviello, L.C.; Hashiro, G.M.; Hernandez, C.A.; Morrison, C.A.; Chan, M.; Sawyer, E.M.; Chung, M.H.; Uyehara, C.F. 2004: Dopamine and vasopressin affect organ perfusion differently in vasodilatory septic shock. FASEB Journal 18(4-5): Abstract 830
Ahmadzadeh, A.; Akers, R.M.; Barnes, M.A. 1999: Dopamine antagonist affects growth hormone secretion during the follicular and metestrus phases of the estrous cycle in Holstein cows. Journal of Animal Science 77(Suppl 1): 223
Nicola, S.M.; Deadwyler, S.A. 1999: Dopamine antagonists decrease behavioral output and alter nucleus accumbens cell firing related to cocaine self-administration. Society for Neuroscience Abstracts 25(1-2): 561
Golden, W.C.; Torbey, M.T.; Li, X.; Martin, L.J.; Koehler, R.C. 2003: Dopamine antagonists prevent loss of striatal Na, KATPase activity after hypoxia-ischemia. Pediatric Research 53(4 Part 2): 24A
Yasunari, K.; Kohno, M.; Minami, M.; Maeda, K.; Hanehira, T.; Junichi, J. 2000: Dopamine as a novel antimigration factor of vascular smooth muscle cells through D1A and D1B dopamine receptors. Hypertension 36(4): 708
Zhang, M.Z.; Yao, B.; Mckama, J.A.; Harris, R.C. 2003: Dopamine attenuates renal cortical COX-2 expression. Journal of the American Society of Nephrology 14(Abstracts Issue): 327A
Pedrosa, R.; Soares, D.S.lva, P. 2002: Dopamine autoxidation induces neuronal death through generation of H2O2. British Journal of Pharmacology 135(Proceedings Suppl): 353P
Cubells, J.F.; Zabetian, C.P.; Anderson, G.M.; Kranzler, H.R.; Ichinose, H.; Nagatsu, T.; Gelernte 2000: Dopamine beta-hydroxylase Genotype-phenotype relationships. American Journal of Medical Genetics 96(4): 508
Yamamoto, K.; Cubells, J.F.; Gelernter, J.; Benkelfat, C.; Lalonde, P.; Bloom, D.; Lal, S.; Labelle, A.; Rouleau, G.; Joober, R. 2000: Dopamine beta-hydroxylase gene and schizophrenia. American Journal of Medical Genetics 96(4): 528
Willour, V.L.; Potash, J.B.; Mackinnon, D.F.; Simpson, S.G.; Huo, Y.; Depaulo, J.R.; Mcinnis, M.G. 2000: Dopamine beta-hydroxylase linkage study in 65 multiplex bipolar families. American Journal of Human Genetics 67(4 Suppl 2): 331
Kim, D.H.; Kim, S.Y.; Choi, J.S.; Yoo, K.H.; Jung, H.L.; Lee, J.A.; Sung, K.W.; Koo, H.H. 2003: Dopamine beta-hydroxylase mRNA can be used as more sensitive and reliable target of RT-PCR than tyrosine hydroxylase mRNA for the detection of minimal neuroblastoma cells in peripheral blood. Proceedings of the American Association for Cancer Research 44: 704
Matsuda, M.; Horseman, N.D. 2002: Dopamine beta-hydroxylase-like proteins in the mouse mammary gland. Zoological Science 19(12): 1492
Wimalasena, K.; Alliston, K.R. 1999: Dopamine beta-monooxygenase /1- -1,4-cyclohexadiene reaction Relative activation energy parameters and evidence for temperature independent isotope effects. FASEB Journal 13(7): A1365
Osborn, D.A.; Evans, N.; Kluckow, M. 2002: Dopamine but not dobutamine increases left ventricular stress, but neither improves LV contractility in very preterm infants. Pediatric Research 51(4 Part 2): 386A
Scheller, C.; Jenuwein, M.; Czub, S.; Ter Meulen, V.; Riederer, P.; Koutsilieri, E. 2003: Dopamine deficits and regulation of the cAMP second messenger system in brains of SIV-infected rhesus monkeys. Journal of Neurovirology 9(Suppl 3): 80
Derwort, K.; Liersch, A.; Kuemmel, H.; Gerlach, M.; Steigerwald, F.; Deuschl, G.; Illert, M. 2001: Dopamine depletion and gait analysis in a chronic MPTP-model for Parkinsons disease in cats. Pfluegers Archiv European Journal of Physiology 441(6 Suppl): R265
Fan, S.F.; Yazulla, S. 2000: Dopamine depletion suppresses IK and alters the D1-mediated effects of ascorbate on IK of goldfish bipolar cells. IOVS Investigative Ophthalmology and Visual Science 41(4): S620
Fox, L.E.; Atluri, P.; Lloyd, P.E. 1999: Dopamine differentially modulates the efficacy of two identified motor neurons in Aplysia. Society for Neuroscience Abstracts 25(1-2): 168
Seeman, P.; Tallerico, T.; Ko, F.ço. 2003: Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography. Synapse 49(4): 209-215
Johnson, B.R.; Kloppenburg, P.; Harris Warrick, R.M. 1999: Dopamine effects on inward barium currents in pyloric neurons of the lobster stomatogastric ganglion. Society for Neuroscience Abstracts 25(1-2): 1642
Liet, J-Michel.; Boscher, Cécile.; Gras-Leguen, Cèle.; Gournay, Véronique.; Debillon, T.; Rozé, J-Christophe. 2002: Dopamine effects on pulmonary artery pressure in hypotensive preterm infants with patent ductus arteriosus. Journal of Pediatrics 140(3): 373-375
Lavin, A.; Grace, A.A. 1999: Dopamine enhancement of cortical neuron excitability is dependent on the state of the membrane potential. Society for Neuroscience Abstracts 25(1-2): 1659
Kudwa, A.E.; Gustaffson, J.A.; Rissman, E.F. 2002: Dopamine facilitates display of lordosis behavior in male mice. Hormones and Behavior 41(4): 476-477
Brady, H.R.; Power, D.A. 1999: Dopamine for the treatment of acute renal failure and septic shock Scientific rationale, experimental studies and clinical trials. Clinical and Experimental Pharmacology and Physiology 26(Suppl ): S64-S65
Syvalahti, E.; Hietala, J. 2001: Dopamine function in neuroleptic-naive schizophrenia. Bolis, C Liana Author, Pani, Luca Author, Licinio, Julio Author Dopaminergic system: Evolution from biological to clinical aspects 139-146
Swanson, J.M.; Flodman, P.; Kennedy, J.; Spence, M.A.; Moyzis, R.; Schuck, S.; Murias, M.; Moriarity, J.; Barr, C.; Smith, M.; Posner, M. 2000: Dopamine genes and ADHD. Neuroscience and Biobehavioral Reviews 24(1): 21-25
Martucci, L.; Kennedy, J.L. 2001: Dopamine genes and neuropsychiatric disease. Bolis, C Liana Author, Pani, Luca Author, Licinio, Julio Author Dopaminergic system: Evolution from biological to clinical aspects 181-192
Schaub, M.; Ploetz, C.; Yard, B.; Braun, C.; Schnuelle, P.; Van Der Woude, F.J. 2002: Dopamine improves graft function of kidneys from brain dead donors. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 357A
Weiner, I.; Joel, D. 2002: Dopamine in schizophrenia Dysfunctional information processing in basal ganglia Thalamocortical split circuits. Di Chiara, Gaetano Handbook of Experimental Pharmacology Dopamine in the CNS II 417-471
Augood, S.J.; Hollingsworth, Z.R.; Penney, J.B.Jr.; Standaert, D.G. 1999: Dopamine in the human subthalamic nucleus TH-immunoreactivity, dopamine D1 and D2 receptor binding and D1 and D2 receptor mRNA. Society for Neuroscience Abstracts 25(1-2): 379
Ridge, K.M.; Dada, L.A.; Sznajder, J.I.sha 2000: Dopamine increases Na,K-ATPase function via a novel PKC. Molecular Biology of the Cell 11(Suppl): 498a-499a
Schroeder, A.; Zhang, X.; Erickson, K. 2000: Dopamine increases outflow facility in the human eye in vitro. IOVS Investigative Ophthalmology and Visual Science 41(4): S575
Dmitrieva, R.L.; Doris, P.A. 2001: Dopamine increases sodium pump inhibitor production by the adrenal cortex. FASEB Journal 15(5): A774
Cohen, E.D.; Dowling, J.E. 2001: Dopamine increases the frequency of calcium action potentials in rod dominant bipolar cells of the cyprinid retina. IOVS Investigative Ophthalmology and Visual Science 42(4): S672
Brismar, H.; Asghar, M.; Carey, R.M.; Greengard, P.; Aperia, A. 1999: Dopamine induced recruitment of D1 receptors to the plasma membrane. Clinical and Experimental Pharmacology and Physiology 26(Suppl ): S54
Schaub, M.; Gerbaulet, D.; Ploetz, C.; Fang, L.; Yard, B.; Braun, C.; Schnuelle, P.; Van Der Woude, F.J. 2001: Dopamine induces hemoxygenase-1 in kidneys of brain dead donors. Kidney and Blood Pressure Research 24(4-6): 334
Porat, S.; Premkumar, A.; Simantov, R. 2001: Dopamine induces phenotypic differentiation or apoptosis in a dose-dependent fashion: involvement of the dopamine transporter and p53. Developmental Neuroscience 23(6): 432-440
Bianchi, P.; Seguelas, M.H.; Parini, A.; Cambon, C. 2001: Dopamine induces proximal tubule cell apoptosis through hydrogen peroxide produced by monoamine oxidases. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 606A
Berger, S.P.; Hunger, M.; Yard, B.; Schnulle, P.; Van Der Woude, J.F.kko 1999: Dopamine induces the expression of heme oxygenase-1 by endothelial cells in vitro. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 696A
Felmet, K.; Fiedor, M.; Carcillo, J. 2002: Dopamine infusion, hypoprolactinemia, and secondary infection in critically ill children. Pediatric Research 51(4 Part 2): 44A
Efendiev, R.; Bertorello, A.M.; Pedemonte, C.H. 1999: Dopamine inhibition and PMA activation of proximal tubule Na+,K+-ATPase activity are mediated by PKC-zeta and PKC-beta, respectively. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 468A
Ogilvie, J.M.; Speck, J.D. 2000: Dopamine inhibition increases photoreceptor survival in rd mouse retinal organ cultures. IOVS Investigative Ophthalmology and Visual Science 41(4): S332
Miyazaki, T.; Lacey, M.G. 1999: Dopamine inhibits GABA release in substantia nigra via activation of presynaptic D1-like receptors. Society for Neuroscience Abstracts 25(1-2): 379
Gomes, P.; Vieira Coelho, M.A.; Soares, D.S.lva, P. 2000: Dopamine inhibits Na+-K+ ATPase activity through stimulation of both D1 and D2 receptor by cAMP-dependent and cAMP-independent pathways. FASEB Journal 14(4): A331
Hu, M.C.; Quinones, H.; Gisler, S.; Murer, H.; Moe, O.W. 2001: Dopamine inhibits exocytotic insertion of Na/H exchanger NHE3 into the plasma membrane. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 5A
Crochet, S.; Sakai, K. 2002: Dopamine inhibits paradoxical sleep via alpha-2 adrenoceptors, but enhances sleep via D2/D3 dopamine receptors A microdialysis study in the CAT. Journal of Sleep Research 11(Suppl 1): 42-43
Shulman, L.M.; Fox, D.A. 1999: Dopamine inhibits rod Na+,K+-ATPase via a 12 -hete induced release of calcium through the low-conductance state of the mitochondrial permeability transition pore. IOVS Investigative Ophthalmology and Visual Science 40(4): S372
Fudge, J.L.; Haber, S.N. 1999: Dopamine innervation of the amygdala in primates. Society for Neuroscience Abstracts 25(1-2): 2172
Levite, M.; Sobko, A.; Cahalon, L.; Hershkoviz, R.; Attali, B. 2001: Dopamine interacts directly with its D3 receptor on normal human T-cells, activates b1 integrins and triggers adhesion to fibronectin. FASEB Journal 15(4): A340
Koutsilieri, E.; Scheller, C.; Czub, S.; Sopper, S.; Ter Meulen, V.; Riederer, P. 2002: Dopamine is a pathogenetic factor in HIV-induced Neuro-AIDS. Nagatsu, Toshiharu , Reprint Author, Nabeshima, Toshitaka, McCarty, Richard, Goldstein, David S Catecholamine research: From molecular insights to clinical medicine: 475-478
Carr, M.; Shanahan, F.L.J.; O'connell, D. 1999: Dopamine is a potential mucosal neuroimmune modulator in health and inflammatory bowel disease. Gastroenterology 116(4 Part 2): A677
Koutsilieri, E.; Czub, S.; Scheller, C.; Sopper, S.; Mueller, J.; Czub, M.; Gosztonyi, G.; Ter Meulen, V.; Riederer, P. 2003: Dopamine is implicated in the pathophysiology of HIV-dementia. Journal of Neurovirology 9(Suppl 3): 6
Li, L.; Dowling, J.E. 1999: Dopamine is required for maintenance of dark-adapted visual sensitivity in zebrafish. IOVS Investigative Ophthalmology and Visual Science 40(4): S235
Dent, M.F.; Neill, D.B. 1999: Dopamine levels in medial prefrontal cortex differentially affect delayed alternation but not water maze performance. Society for Neuroscience Abstracts 25(1-2): 890
Zayek, M.M.; Hamm, C.R.Jr; O'donnell, K.; Flowers, P.; Eyal, F.G. 1999: Dopamine may not improve cerebral blood flow after cardiac depression secondary to intestinal ischemia-reperfusion injury. Pediatric Research 45(4 Part 2): 234A
Montine, T.J.; Amarnath, V.; Picklo, M.J.; Sidell, K.R.; Zhang, J.; Graham, D.G. 2000: Dopamine mercapturate can augment dopaminergic neurodegeneration. Drug Metabolism Reviews 32(3-4): 363-376
Mora Ferrer, C.; Gangluff, V. 2000: Dopamine modulates flicker fusion frequency in goldfish. IOVS Investigative Ophthalmology and Visual Science 41(4): S939
Kline, D.D.; Takacs, K.; Glazebrook, P.; Ficker, E.; Kunze, D.L. 2002: Dopamine modulates the first synapse of the nucleus tractus solitarius. FASEB Journal 16(5): A812
Onn, S.P.; Grace, A.A. 1999: Dopamine modulation of afferent-evoked synaptic responses in identified prefrontal cortex pyramidal neurons Correspondence with axonal morphology. Synapse (New York) 33(1): 1-15
Grace, A.A.; Fienberg, A.A.; Greengard, P.; Onn, S.P. 1999: Dopamine modulation of gap junctional permeability via DARPP-32 signal transduction pathway. Society for Neuroscience Abstracts 25(1-2): 1159
Kloppenburg, P.; Zipfel, W.R.; Webb, W.W.; Harris Warrick, R.M. 1999: Dopamine modulation of localized Ca++ accumulation in identified motoneurons monitored by multi-photon excitation microscopy. Society for Neuroscience Abstracts 25(1-2): 1038
Witta, J.; Baffi, J.S.; Palkovits, M.; Mezey, E.; Castillo, S.O.; Yang, S.; Eells, J.; Nikodem, V.M. 1999: Dopamine neuron precursors in the ventral midbrain arrest from terminal differentiation Express general neuronal markers and innervate the striatum in Nurr1 disrupted mice. Society for Neuroscience Abstracts 25(1-2): 1210
Morzorati, S.L.; Marunde, R.L. 2003: Dopamine neuronal activity in the VTA of alcohol-naive high and low alcohol drinking rats. Alcoholism Clinical and Experimental Research 27(5 Suppl): 93A
Ishiguro, H.; Yamada, K.; Sawada, H.; Nishii, K.; Sawada, M.; Goto, J.; Kanazawa, I.; Nagatsu, T. 2002: Dopamine neurons are not affected by expanded polyglutamine stretches in HD gene knock-in mice. Nagatsu, Toshiharu , Reprint Author, Nabeshima, Toshitaka, McCarty, Richard, Goldstein, David S Catecholamine research: From molecular insights to clinical medicine: 99-102
Satoh, T.; Nakai, S.; Kimura, M. 2003: Dopamine neurons encode teaching signals for trial-and-error behavioral decision learning. Neuroscience Research Suppl (26): S88
Condie, B.G.; Schulz, T.C.; Palmarini, G.M.; Pensa, K.; Davidson, B. 2004: Dopamine neurons from human embryonic stem cells. FASEB Journal 18(4-5): Abstract 755
Dal Bo, G.; St Gelais, F.; Danik, M.; Cotton, M.; Williams, S.; Trudeau, L.E. 2003: Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to Dopamine. Society for Neuroscience Abstract Viewer and Itinerary Planner: Abstract No. 475-16
Mclaughlin, B. 2001: Dopamine neurotoxicity and neurodegeneration. Chesselet, Marie-Francoise Contemporary Clinical Neuroscience Molecular mechanisms of neurodegenerative diseases 195-231
Garcia, J.; Rettori, D.; Cadenas, E. 2002: Dopamine oxidation in cell culture medium. Free Radical Biology and Medicine 33(Suppl 2): S308
Hankins, M.W. 2000: Dopamine pathways are selectively affected in the senile retina. IOVS Investigative Ophthalmology and Visual Science 41(4): S942
Viggiano, D.; Ruocco, L.A.; Sadile, A.G. 2003: Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder. Neuroscience and Biobehavioral Reviews 27(7): 623-637
Cohen, E.D.; Dowling, J.E. 2000: Dopamine potentiates synaptic transmission from bipolar cells in the cyprinid retina. IOVS Investigative Ophthalmology and Visual Science 41(4): S936
Jain, L.; Chen, X.J.; Eaton, D.C. 2001: Dopamine promotes lung fluid clearance through activation of amiloride sensitive sodium channels in alveolar epithelia. Pediatric Research 49(4 Part 2): 288A
Zhang, S.; Kashii, S.; Yamauchi, T.; Honda, Y.; Akaike, A. 2001: Dopamine protects cultured retinal neurons from glutamate-induced neurotoxicity by suppressing nitric oxide synthase. IOVS Investigative Ophthalmology and Visual Science 42(4): S749
Morimoto, K.; Miyatake, R.; Nakamura, M. 2002: Dopamine psychosis in schizophrenia? Molecular genetic study on delusional disorder. Nagatsu, Toshiharu , Reprint Author, Nabeshima, Toshitaka, McCarty, Richard, Goldstein, David S Catecholamine research: From molecular insights to clinical medicine: 409-412
LaVoie, M.J.; Hastings, T.G. 1999: Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(4): 1484-1491
Tumlin, J.; Finckle, K.; Murray, P.; Shaw, A. 2003: Dopamine receptor 1 agonists in early acute tubular necrosis A prospective, randomized, double blind, placebo-controlled trial of fenoldopam mesylate. Journal of the American Society of Nephrology 14(Abstracts Issue): 774A
Scislowski, P.W.; Jetton, T.L. 1999: Dopamine receptor agonist treatment increases apoptosis and fatty acid oxidation of white adipose tissue in ob/ob mice. Diabetes 48(Suppl 1): A266
Smith, J.; Holder, A. 2003: Dopamine receptor antagonist. Abstracts of Papers American Chemical Society 226(1-2): MEDI 141
Bhat, R.I.; Chari, G.C.; Prasasd, V.K.; Zagariya, A. 2002: Dopamine receptor antagonist alters brain mu receptor regulation in newborn rats exposed prenatally to morphine and cocaine. Pediatric Research 51(4 Part 2): 461A-462A
Strange, P.G. 1999: Dopamine receptor antagonists or inverse agonists as antipsychotics?. Biochemical Society Transactions 27(1): A26
Dickinson, S.D.; Lee, E.; Rindal, K.; Cunningham, C.L. 2001: Dopamine receptor blockade does not interfere with expression of ethanol-induced conditioned place preference. Alcoholism Clinical and Experimental Research 25(5 Suppl A): 64A
Higgs, S.; Cooper, S.J. 2000: Dopamine receptor blockade of midazolam-induced enhancement of palatability A microstructural analysis of licking behaviour in the rat. Journal of Psychopharmacology 14(3 Suppl): A70
Glickstein, S.B.; Schmauss, C. 2001: Dopamine receptor functions: lessons from knockout mice [corrected. Pharmacology and Therapeutics 91(1): 63-83
Tsai, S.-J.; Hong, C.-J. 2003: Dopamine receptor hetero-oligomerization in the pathogenesis of schizophrenia: qualitative as opposed to quantitative notions of dopaminergic receptors. Schizophrenia Research 63(1-2): 197-198
Ricci, A.; Barili, P.; Bronzetti, E.; Felici, L.; Greco, S.; Mariotta, S.; Amenta, F. 1999: Dopamine receptor immunohistochemistry in the human pulmonary artery. Clinical and Experimental Pharmacology and Physiology 26(Suppl ): S67
Ferrani Kile, K.; Leslie, S.W.; Morrisett, R.A. 1999: Dopamine receptor modulation of NMDA responses in hippocampus and neostriatum Occlusion of ethanol inhibition. Alcoholism Clinical and Experimental Research 23(5 Suppl): 48A
Andersen, S.L.; Thompson, A.T.; Rutstein, M.; Hostetter, J.C.; Teicher, M.H. 2000: Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse 37(2): 167-169
Hussain, T.; Kotak, D.K.; Abdul Wahab, R.; Lokhandwala, M.F. 1999: Dopamine receptor signal transduction in renal proximal tubules of obese zucker rats. Clinical and Experimental Pharmacology and Physiology 26(Suppl ): S55
Ragnauth, A.; Znamensky, V.; Bodnar, R.J. 1999: Dopamine receptor subtype antagonism alters mu opioid agonist-induced feeding in the rat nucleus accumbens. Society for Neuroscience Abstracts 25(1-2): 1883
Yu, W.Z.; Sclafani, A.; Bodnar, R.J. 1999: Dopamine receptor subtype antagonism suppresses the acquisition of conditioned flavor preferences in sham-feeding rats. Society for Neuroscience Abstracts 25(1-2): 1883
Blaustein, J.D.; Lubbers, L.S.; Meredith, J.; Wade, G.N. 1999: Dopamine receptor subtypes in progestin receptor -rich regions of the hypothalamus in female rats. Society for Neuroscience Abstracts 25(1-2): 1881
Felici, L.; Barili, P.; Bronzetti, E.; Ricci, A.; Amenta, F. 1999: Dopamine receptor subtypes in rat cerebral vessels An immunohistochemical study. Clinical and Experimental Pharmacology and Physiology 26(Suppl ): S65
Dikeos, D.G.; Papadimitriou, G.N.; Karadima, G.; Daskalopoulou, E.G.; Avramopoulos, D.; Stefanis, C.N. 2000: Dopamine receptors D2 and D3 genes in affective disorders. Neuropsychopharmacology 23(S2): S137
Schmauss, C. 2000: Dopamine receptors Novel insights from biochemical and genetic studies. Neuroscientist 6(2): 127-138
Civelli, O.; Bunzow, J.R.; Grandy, D.K.; Machida, C.A. 1999: Dopamine receptors and genes. Official Gazette of the United States Patent and Trademark Office Patents 1220(2): 1598
Patel, A.V.; Goyal, R.K. 2001: Dopamine receptors in mast cell degranulation. Indian Journal of Pharmacology 33(1): 67
Arias, C.; Mlewski, E.C.; Hansen, C.; Molina, J.C.; Paglini, M.G.; Spear, N.E. 2010: Dopamine receptors modulate ethanol's locomotor-activating effects in preweanling rats. Developmental Psychobiology 52(1): 13-23
Emilien, G.; Maloteaux, J.M.; Geurts, M.; Hoogenberg, K.; Cragg, S. 1999: Dopamine receptors--physiological understanding to therapeutic intervention potential. Pharmacology and Therapeutics 84(2): 133-156
Gonzalez Islas, C.; Hablitz, J.J. 1999: Dopamine reduces evoked IPSCs in layer II-III pyramidal neurons from rat cortex. Society for Neuroscience Abstracts 25(1-2): 1216
Guerrero, C.; Ghosh, A.; Lecuona, E.; Ridge, K.; Santos, E.; Sznajder, J.I. 1999: Dopamine regulates NA,K-adenosine triphosphatase in alveolar epithelial cells via the mitogen-activated protein kinase/extracellular-signal-regulated kinase pathway. Chest 116(1 Suppl): 88s-89s